Medication Guides
Medication guides are FDA- approved documents that address issues that are specific to particular drugs, and can help patients avoid serious adverse events (side effects). This database does not include Medication Guides for FDA-approved allergenic or cellular/tissue products (see FDA Online Label Repository or DailyMed for these Medication Guides). More
Click on drug name to view Medication Guide in PDF format.
| Drug Name | Active Ingredient | Form;Route | Appl. No. | Company | Date | Link |
|---|---|---|---|---|---|---|
| Drug Name | Active Ingredient | Form;Route | Appl. No. | Company | Date | Link |
| Abacavir and LAmivudine | Abacavir Sulfate;Lamivudine | TABLET;ORAL | 204311 | MYLAN LABORATORIES LIMITED | 12/22/2023 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/204311s000lbl.pdf#page=34 |
| Abilify | Aripiprazole | SOLUTION;ORAL | 021713 | OTSUKA | 02/05/2020 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021436s044s045,021713s035s036,021729s027s028,021866s029s030lbl.pdf#page=77 |
| Abilify | Aripiprazole | TABLET, ORALLY DISINTEGRATING;ORAL | 021729 | OTSUKA | 02/05/2020 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021436s044s045,021713s035s036,021729s027s028,021866s029s030lbl.pdf#page=77 |
| Abilify | Aripiprazole | TABLET;ORAL | 021436 | OTSUKA | 01/22/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/021436s046s050lbl.pdf#page=66 |
| Abilify | Aripiprazole | INJECTABLE;INTRAMUSCULAR | 021866 | OTSUKA | 02/05/2020 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021436s044s045,021713s035s036,021729s027s028,021866s029s030lbl.pdf#page=77 |
| Abilify Asimtufii | Aripiprazole Monohydrate | EXTENDED-RELEASE, INJECTABLE SUSPENSION; INTRAMUSCULAR | 217006 | OTSUKA PHARMACEUTICAL CO., LTD | 01/22/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/217006s002lbl.pdf#page=40 |
| Abilify Maintena Kit | Aripiprazole | FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | 202971 | OTSUKA PHARM CO LTD | 01/22/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/202971s019lbl.pdf#page=46 |
| Abilify Mycite Kit | Aripiprazole | TABLET;ORAL | 207202 | OTSUKA | 01/22/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/207202s009lbl.pdf#page=48 |
| Abrilada | Adalimumab-Afzb | INJECTABLE;INJECTION | 761118 | PFIZER INC | 10/04/2023 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761118s007lbl.pdf#page=47 |
| Absorica | Isotretinoin | CAPSULE;ORAL | 021951 | SUN PHARM INDS INC | 06/16/2026 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/021951s029lbl.pdf#page=23 |
| Abstral | Fentanyl Citrate | TABLET;SUBLINGUAL | 022510 | SENTYNL THERAPS INC | 10/07/2019 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022510s018lbl.pdf#page=29 |
| Accutane | Isotretinoin | CAPSULE;ORAL | 018662 | HOFFMANN LA ROCHE | 10/22/2010 | http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/018662s061MedGuide.pdf |
| Aciphex | Rabeprazole Sodium | TABLET, DELAYED RELEASE;ORAL | 020973 | WOODWARD | 07/18/2023 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/020973s043lbl.pdf#page=34 |
| Aciphex Sprinkle | Rabeprazole Sodium | CAPSULE, DELAYED RELEASE;ORAL | 204736 | AYTU | 11/27/2020 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/204736s012lbl.pdf#page=21 |
| Actemra | Tocilizumab | INJECTABLE; INJECTION | 125276 | GENENTECH | 08/08/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/125276s149lbl.pdf#page=59 |
| Actemra | Tocilizumab | INJECTABLE;INTRAVENOUS, SUBCUTANEOUS | 125472 | GENENTECH | 08/08/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/125472s061lbl.pdf#page=59 |
| Acthar Gel | Corticotropin | INJECTABLE;INJECTION | 008372 | MALLINCKRODT ARD | 03/01/2024 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/008372s074lbl.pdf#page=19 |
| Actiq | Fentanyl Citrate | TROCHE/LOZENGE;TRANSMUCOSAL | 020747 | CEPHALON | 12/15/2023 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/020747s062lbl.pdf#page=44 |
| Actonel | Risedronate Sodium | TABLET;ORAL | 020835 | APIL | 02/03/2026 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/020835s054lbl.pdf#page=44 |
| Actonel With Calcium (Copackaged) | Calcium Carbonate; Risedronate Sodium | TABLET;ORAL | 021823 | WARNER CHILCOTT | 04/08/2015 | http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/021823s011lbl.pdf#page=27 |
| Actoplus MET | Metformin Hydrochloride; Pioglitazone Hydrochloride | TABLET;ORAL | 021842 | TAKEDA PHARMS USA | 08/18/2026 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/021842s027lbl.pdf#page=36 |
| Actoplus MET XR | Metformin Hydrochloride; Pioglitazone Hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 022024 | TAKEDA PHARMS USA | 12/21/2017 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/022024s014lbl.pdf#page=41 |
| Actos | Pioglitazone Hydrochloride | TABLET;ORAL | 021073 | TAKEDA PHARMS USA | 12/21/2017 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021073s049lbl.pdf#page=35 |
| Adasuve | Loxapine | POWDER;INHALATION | 022549 | ALEXZA PHARMS | 02/01/2022 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022549s010lbl.pdf#page=28 |
| Adderall 10 | Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate | TABLET;ORAL | 011522 | TEVA WOMENS | 10/13/2023 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/011522s045lbl.pdf#page=15 |
| Adderall 12.5 | Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate | TABLET;ORAL | 011522 | TEVA WOMENS | 10/13/2023 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/011522s045lbl.pdf#page=15 |
| Adderall 15 | Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate | TABLET;ORAL | 011522 | TEVA WOMENS | 10/13/2023 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/011522s045lbl.pdf#page=15 |
| Adderall 20 | Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate | TABLET;ORAL | 011522 | TEVA WOMENS | 10/13/2023 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/011522s045lbl.pdf#page=15 |
| Adderall 30 | Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate | TABLET;ORAL | 011522 | TEVA WOMENS | 02/25/2022 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/011522s044lbl.pdf#page=15 |
| Adderall 5 | Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate | TABLET;ORAL | 011522 | TEVA WOMENS | 02/25/2022 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/011522s044lbl.pdf#page=15 |
| Adderall 7.5 | Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate | TABLET;ORAL | 011522 | TEVA WOMENS | 02/25/2022 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/011522s044lbl.pdf#page=15 |
| Adderall XR 10 | Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate | CAPSULE, EXTENDED RELEASE;ORAL | 021303 | TAKEDA PHARMS USA | 06/23/2026 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/021303s040lbl.pdf#page=22 |
| Adderall XR 15 | Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate | CAPSULE, EXTENDED RELEASE;ORAL | 021303 | TAKEDA PHARMS USA | 09/23/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/021303s042lbl.pdf#page=22 |
| Adderall XR 20 | Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate | CAPSULE, EXTENDED RELEASE;ORAL | 021303 | TAKEDA PHARMS USA | 09/23/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/021303s042lbl.pdf#page=22 |
| Adderall XR 25 | Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate | CAPSULE, EXTENDED RELEASE;ORAL | 021303 | TAKEDA PHARMS USA | 09/23/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/021303s042lbl.pdf#page=22 |
| Adderall XR 30 | Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate | CAPSULE, EXTENDED RELEASE;ORAL | 021303 | TAKEDA PHARMS USA | 09/23/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/021303s042lbl.pdf#page=22 |
| Adderall XR 5 | Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate | CAPSULE, EXTENDED RELEASE;ORAL | 021303 | TAKEDA PHARMS USA | 09/23/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/021303s042lbl.pdf#page=22 |
| Addyi | Flibanserin | TABLET;ORAL | 022526 | SPROUT PHARMS | 09/29/2021 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022526s009lbl.pdf#page=23 |
| Adempas | Riociguat | TABLET;ORAL | 204819 | BAYER HLTHCARE | 09/10/2021 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/204819s015lbl.pdf#page=24 |
| Adhansia XR | Methylphenidate Hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 212038 | PURDUE PHARMA LP | 06/28/2021 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/212038s002lbl.pdf#page=25 |
| Adlyxin | Lixisenatide | SOLUTION;SUBCUTANEOUS | 208471 | SANOFI-AVENTIS US | 03/12/2026 | http://www.accessdata.fda.gov/drugsatfda_docs/label/2026/208471s012lbl.pdf#page=25 |
| Aduhelm | Aducanumab-Avwa | INJECTABLE; INJECTION | 761178 | BIOGEN INC | 08/30/2023 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761178s011lbl.pdf#page=26 |
| Adzenys ER | Amphetamine | SUSPENSION, EXTENDED RELEASE;ORAL | 204325 | NEOS THERAPS INC | 02/25/2022 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/204325s003lbl.pdf#page=26 |
| Adzenys XR-Odt | Amphetamine | TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE;ORAL | 204326 | NEOS THERAPS | 09/23/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/204326s020lbl.pdf#page=28 |
| Afrezza | Insulin Recombinant Human | POWDER;INHALATION | 022472 | MANNKIND | 05/28/2026 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/022472s029lbl.pdf#page=22 |
| Alhemo | Concizumab-Mtci | INJECTABLE;SUBCUTANEOUS | 761315 | NOVO NORDISK | 07/31/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/761315s003lbl.pdf#page=12 |
| Alhemo | Concizumab-Mtci | INJECTION | 761428 | NOVO NORDISK INC. | 07/31/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/761428s000lbl.pdf#page=12 |
| Alkindi Sprinkle | Hydrocortisone | GRANULE;ORAL | 213876 | ETON | 06/05/2024 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/213876s002lbl.pdf#page=14 |
| Alvaiz | Eltrombopag Choline | TABLET;ORAL | 216677 | TEVA PHARMACEUTICALS | 11/29/2023 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/216774s000lbl.pdf#page=30 |
| Alyftrek | Vanzacaftor, Tezacaftor, Deutivacaftor | TABLET | 218730 | VERTEX PHARMACEUTICALS INC | 03/27/2026 | http://www.accessdata.fda.gov/drugsatfda_docs/label/2026/218730s001lbl.pdf#page=23 |
| Ambien | Zolpidem Tartrate | TABLET;ORAL | 019908 | SANOFI AVENTIS US | 02/23/2022 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/019908s40s044s047lbl.pdf#page=24 |
| Ambien CR | Zolpidem Tartrate | TABLET, EXTENDED RELEASE;ORAL | 021774 | SANOFI AVENTIS US | 02/23/2022 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021774s021s025s028lbl.pdf#page=27 |
| Amjevita | Adalimumab-Atto | INJECTABLE;INJECTION | 761024 | AMGEN INC | 10/16/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/761024s026lbl.pdf#page=60 |
| Ampyra | Dalfampridine | TABLET, EXTENDED RELEASE;ORAL | 022250 | ACORDA | 11/18/2021 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022250s019lbl.pdf#page=13 |
| Anafranil | Clomipramine Hydrochloride | CAPSULE;ORAL | 019906 | SPECGX LLC | 05/10/2019 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/019906s043lbl.pdf#page=27 |
| Anaprox | Naproxen Sodium | TABLET;ORAL | 018164 | ATNAHS PHARMA US | 11/21/2024 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/017581s117,018164s067,020067s026lbl.pdf |
| Anaprox DS | Naproxen Sodium | TABLET;ORAL | 018164 | ATNAHS PHARMA US | 05/13/2024 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/017581s115,018164s065,020067s024lbl.pdf#page=23 |
| Androgel | Testosterone | GEL, METERED;TRANSDERMAL | 022309 | ABBVIE | 07/11/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/022309s022lbl.pdf#page=27 |
| Androgel | Testosterone | GEL;TRANSDERMAL | 022309 | ABBVIE | 07/11/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/022309s022lbl.pdf#page=27 |
| Androgel | Testosterone | GEL;TRANSDERMAL | 021015 | ABBVIE | 07/11/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/021015s047lbl.pdf#page=25 |
| Androgel | Testosterone | GEL, METERED;TRANSDERMAL | 021015 | ABBVIE | 05/30/2019 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/021015s047lbl.pdf#page=25 |
| Ansaid | Flurbiprofen | TABLET;ORAL | 018766 | PHARMACIA AND UPJOHN | 05/09/2016 | http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/018766s015MedGuide.pdf |
| Anzupgo | Delgocitinib | CREAM | 219155 | LEO PHARMA AS | 07/10/2026 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/219155s004lbl.pdf#page=14 |
| Apadaz | Acetaminophen; Benzhydrocodone Hydrochloride | TABLET;ORAL | 208653 | KVK TECH INC | 12/15/2023 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/208653s008lbl.pdf#page=40 |
| Aplenzin | Bupropion Hydrobromide | TABLET, EXTENDED RELEASE;ORAL | 022108 | BAUSCH | 11/05/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/022108s026lbl.pdf#page=28 |
| Aptensio XR | Methylphenidate Hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 205831 | RHODES PHARMS | 09/23/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/205831s012lbl.pdf#page=19 |
| Aptiom | Eslicarbazepine Acetate | TABLET;ORAL | 022416 | SUNOVION PHARMS INC | 03/15/2019 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022416s011lbl.pdf#page=25 |
| Aptryxol | Desvenlafaxine | TABLET,EXTENDED RELEASE;ORAL | 205583 | SUN PHARMACEUTICAL | 08/18/2023 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/205583s014lbl.pdf#page=30 |
| Aqvesme | Mitapivat | TABLET | 216196 | AGIOS PHARMACEUTICALS INC | 12/23/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/216196s003lbl.pdf#page=20 |
| Aranesp | Darbepoetin Alfa | VIAL; INTRAVENOUS | 103951 | AMGEN | 01/30/2019 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/103951s5377lbl.pdf#page=25 |
| Aranesp | Darbepoetin Alfa | VIAL; SUBCUTANEOUS | 103951 | AMGEN | 01/30/2019 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/103951s5377lbl.pdf#page=25 |
| Arcapta Neohaler | Indacaterol Maleate | POWDER;INHALATION | 022383 | NOVARTIS | 07/30/2021 | http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/022383s000MedG.pdf |
| Arikayce Kit | Amikacin Sulfate | SUSPENSION, LIPOSOMAL;INHALATION | 207356 | INSMED INC | 02/10/2023 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/207356s004lbl.pdf#page=15 |
| Aristada | Aripiprazole LAuroxil | SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | 207533 | ALKERMES INC | 01/22/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/207533s031lbl.pdf#page=36 |
| Aristada Initio Kit | Aripiprazole LAuroxil | SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | 209830 | ALKERMES INC | 01/22/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/209830s020lbl.pdf#page=31 |
| Arthrotec | Diclofenac Sodium; Misoprostol | TABLET, DELAYED RELEASE;ORAL | 020607 | PFIZER | 11/21/2024 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/020607s043lbl.pdf#page=33 |
| Arymo ER | Morphine Sulfate | TABLET, EXTENDED RELEASE;ORAL | 208603 | ZYLA | 10/07/2019 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/208603s005lbl.pdf#page=34 |
| Arynta | Lisdexamfetamine Dimesylate | ORAL;SOLUTION | 219847 | AZURITY PHARMACEUTICALS INC | 06/16/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/219847s000lbl.pdf#page=37 |
| Astagraf XL | Tacrolimus | CAPSULE, EXTENDED RELEASE;ORAL | 050709 | ASTELLAS | 11/22/2022 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/050708s054,050709s047,204096s010lbl.pdf#page=91 |
| Astagraf XL | Tacrolimus | CAPSULE, EXTENDED RELEASE;ORAL | 050708 | ASTELLAS | 09/14/2023 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/050708s054,050709s047,204096s010lbl.pdf#page=91 |
| Astagraf XL | Tacrolimus | CAPSULE, EXTENDED RELEASE;ORAL | 210115 | ASTELLAS | 09/14/2023 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/210115s006lbl.pdf#page=33 |
| Astagraf XL | Tacrolimus | CAPSULE, EXTENDED RELEASE;ORAL | 204096 | ASTELLAS | 09/14/2023 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/204096s011lbl.pdf#page=33 |
| Atelvia | Risedronate Sodium | TABLET, DELAYED RELEASE;ORAL | 022560 | APIL | 02/03/2026 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/022560s013bl.pdf |
| Ativan | Lorazepam | TABLET;ORAL | 017794 | BAUSCH | 01/13/2023 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/017794s049lbl.pdf#page=14 |
| Atoncy | Atomoxetine | SOLUTION | 220320 | MAP77 LLC | 03/20/2026 | http://www.accessdata.fda.gov/drugsatfda_docs/label/2026/220320Orig1s000lbl.pdf#page=26 |
| Atzumi | Dihydroergotamine | POWDER;NASAL | 217901 | SATSUMA PHARMACEUTICALS | 04/30/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/217901s000lbl.pdf#page=19 |
| Aubagio | Teriflunomide | TABLET;ORAL | 202992 | SANOFI AVENTIS US | 02/11/2026 | http://www.accessdata.fda.gov/drugsatfda_docs/label/2026/202992s018lbl.pdf#page=26 |
| Austedo | Deutetrabenazine | TABLET;ORAL | 216354 | TEVA NEUROSCIENCE | 02/28/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/208082s018,216354s008lbl.pdf#page=29 |
| Austedo | Deutetrabenazine | TABLET;ORAL | 208082 | TEVA BRANDED PHARM | 02/28/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/208082s018,216354s008lbl.pdf#page=29 |
| Auvelity | Bupropion; Dextromethorphan | TABLET, EXTENDED RELEASE; ORAL | 215430 | AXSOME INC | 04/30/2026 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/215430s009s018lbl.pdf#page=36 |
| Avandamet | Metformin Hydrochloride; Rosiglitazone Maleate | TABLET;ORAL | 021410 | SB PHARMCO | 04/05/2017 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021410s040lbl.pdf#page=38 |
| Avandaryl | Glimepiride; Rosiglitazone Maleate | TABLET;ORAL | 021700 | SB PHARMCO | 04/27/2023 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/217006s000lbl.pdf#page=39 |
| Avandia | Rosiglitazone Maleate | TABLET;ORAL | 021071 | WOODWARD | 02/05/2019 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021071s052lbl.pdf#page=38 |
| Aveed | Testosterone Undecanoate | INJECTABLE;INTRAMUSCULAR | 022219 | ENDO PHARMS INC | 08/16/2021 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022219s014lbl.pdf#page=23 |
| Avelox | Moxifloxacin Hydrochloride | TABLET;ORAL | 021085 | BAYER HLTHCARE | 07/11/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/021085s069,021277s065lbl.pdf#page=33 |
| Avelox in Sodium Chloride 0.8% in Plastic Container | Moxifloxacin Hydrochloride | SOLUTION;INTRAVENOUS | 021277 | BAYER HLTHCARE | 07/11/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/021085s069,021277s065lbl.pdf#page=33 |
| Avinza | Morphine Sulfate | CAPSULE, EXTENDED RELEASE;ORAL | 021260 | KING PHARMS LLC | 06/26/2015 | http://www.fda.gov/downloads/Drugs/DrugSafety/UCM311346.pdf |
| Avonex | Interferon Beta-1a | VIAL | 103628 | BIOGEN | 07/28/2023 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/103628s5269lbl.pdf#page=22 |
| Avsola | Infliximab-Axxq | INJECTABLE;INJECTION | 761086 | AMGEN INC | 08/25/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/761086s013lbl.pdf#page=50 |
| Avtozma | Tocilizumab-Anoh | INJECTABLE;INTRAVENOUS, SUBCUTANEOUS | 761420 | CELLTRION | 10/06/2026 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/761420s008lbl.pdf#page=55 |
| Axiron | Testosterone | SOLUTION, METERED;TRANSDERMAL | 022504 | ELI LILLY AND CO | 07/13/2017 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/022504s016lbl.pdf#page=15 |
| Azstarys | Dexmethylphenidate Hydrochloride; Serdexmethylphenidate Chloride | CAPSULE;ORAL | 212994 | COMMAVE THERAP | 09/23/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/212994s012lbl.pdf#page=25 |
| Banzel | Rufinamide | SUSPENSION;ORAL | 201367 | EISAI INC | 05/30/2023 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/201367Orig1s011lbl.pdf#page=19 |
| Banzel | Rufinamide | TABLET;ORAL | 021911 | EISAI INC | 11/28/2019 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021911s017,201367s008lbl.pdf#page=19 |
| Bavencio | Avelumab | INJECTABLE;INJECTION | 761049 | EMD SERONO INC | 06/04/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/761049s021lbl.pdf#page=36 |
| Bavencio | Avelumab | INJECTABLE;INTRAVENOUS | 761078 | EMD SERONO INC | 05/09/2017 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/761078s000lbl.pdf#page=23 |
| Baxdela | Delafloxacin Meglumine | TABLET;ORAL | 208610 | MELINTA | 06/19/2017 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/208610s007,208611s006lbl.pdf#page=28 |
| Baxdela | Delafloxacin Meglumine | POWDER;INTRAVENOUS | 208611 | MELINTA | 12/01/2023 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/208611s007lbl.pdf#page=28 |
| Belbuca | Buprenorphine Hydrochloride | FILM;BUCCAL | 207932 | BDSI | 12/15/2023 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/207932s023lbl.pdf#page=40 |
| Belsomra | Suvorexant | TABLET;ORAL | 204569 | MERCK SHARP DOHME | 03/25/2021 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/204569s008lbl.pdf#page=23 |
| Benlysta | Belimumab | INJECTABLE;INJECTION | 761043 | GLAXOSMITHKLINE LLC | 06/20/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/761043s034lbl.pdf#page=38 |
| Benlysta | Belimumab | INJECTABLE; INJECTION | 125370 | HUMAN GENOME SCIENCES INC. | 06/20/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/125370s085lbl.pdf#page=38 |
| Besremi | Ropeginterferon Alfa-2b-Njft | INJECTABLE;SUBCUTANEOUS | 761166 | PHARMAESSENTIA CORP | 09/01/2026 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/761166s013lbl.pdf#page=20 |
| Betaseron | Interferon Beta-1b | VIAL; SUBCUTANEOUS | 103471 | BAYER HEALTHCARE PHARMS | 07/28/2023 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/103471s5202lbl.pdf#page=19 |
| Bevyxxa | Betrixaban | CAPSULE;ORAL | 208383 | PORTOLA PHARMS INC | 08/24/2020 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/208383s000lbl.pdf#page=20 |
| Bildyos | Denosumab-Nxxp | INJECTABLE;SUBCUTANEOUS | 761444 | SHANGHAI HENLIUS BIOTECH, INC | 10/29/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/761444s000lbl.pdf#page=30 |
| Bimzelx | Bimekizumab-Bkzx | INJECTABLE; SUBCUTANEOUS | 761151 | UCB INC | 09/20/2024 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/761151s005s006s007lbl.pdf#page=29 |
| Binosto | Alendronate Sodium | TABLET, EFFERVESCENT;ORAL | 202344 | ASCEND THERAPS US | 02/03/2026 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/202344s022lbl.pdf#page=26 |
| Blenrep | Belantamab Mafodotin-Blmf | INJECTABLE;INTRAVENOUS | 761158 | GLAXOSMITHKLINE | 02/28/2022 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761158s006lbl.pdf#page=22 |
| Blincyto | Blinatumomab | INJECTABLE;INJECTION | 125557 | AMGEN | 06/14/2024 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/125557s023s026lbl.pdf#page=41 |
| Boncresa | Denosumab | INJECTION | 761456 | AMNEAL PHARMACEUTICALS LLC | 12/19/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/761456s000lbl.pdf#page=30 |
| Boniva | Ibandronate Sodium | INJECTABLE;INTRAVENOUS | 021858 | ROCHE | 01/11/2022 | http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/021858s022lbl.pdf#page=18 |
| Boniva | Ibandronate Sodium | TABLET;ORAL | 021455 | HOFFMANN LA ROCHE | 12/07/2016 | http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/021455s021lbl.pdf#page=19 |
| Bonsity | Teriparatide | SOLUTION;SUBCUTANEOUS | 211939 | ALVOGEN | 08/11/2026 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/211939s021lbl.pdf#page=22 |
| Bosaya | Denosumab-Kyqq | INJECTION | 761436 | BIOCON BIOLOGICS INC | 10/29/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/761436s000lbl.pdf#page=35 |
| Botox | Onabotulinumtoxina | VIAL; SINGLE-USE | 103000 | ALLERGAN | 08/10/2023 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/103000s5327lbl.pdf#page=49 |
| Botox Cosmetic | Onabotulinumtoxina | VIAL; SINGLE-USE | 103000 | ALLERGAN | 08/10/2023 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/103000s5327lbl.pdf#page=49 |
| Braftovi | Encorafenib | CAPSULE;ORAL | 210496 | ARRAY BIOPHARMA INC | 02/24/2026 | http://www.accessdata.fda.gov/drugsatfda_docs/label/2026/210496s021lbl.pdf#page=41 |
| Brekiya | Dihydroergotamine Mesylate, Usp | INJECTABLE;SUBCUTANEOUS | 215400 | AMNEAL PHARMACEUTICALS PVT LTD | 05/14/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/215400s000lbl.pdf#page=14 |
| Brenzavvy | Bexagliflozin | TABLET;ORAL | 214373 | THERACOS BIO | 09/12/2023 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/214373s001lbl.pdf#page=22 |
| Brepocitinib Tosylate | Brepocitinib Tosylate | TABLET | 220106 | PRIOVANT THERAPEUTICS INC | 09/01/2026 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/220106Orig1s000lbl.pdf#page=21 |
| Brexafemme | Ibrexafungerp | TABLET;ORAL | 214900 | SCYNEXIS | 11/03/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/214900s003lbl.pdf#page=18 |
| Brilinta | Ticagrelor | TABLET;ORAL | 022433 | ASTRAZENECA | 03/22/2024 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022433s034lbl.pdf#page=35 |
| Brisdelle | Paroxetine Mesylate | CAPSULE;ORAL | 204516 | SEBELA IRELAND LTD | 02/11/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/204516s009s014lbl.pdf#page=22 |
| Briumvi | Ublituximab-Xiiy | INJECTABLE;INJECTION | 761238 | TG Therapeutics | 08/18/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/761238s022s025lbl.pdf#page=19 |
| Briviact | Brivaracetam | SOLUTION;INTRAVENOUS | 205837 | UCB INC | 08/28/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/205836s017,205837s014,205838s015lbl.pdf#page=18 |
| Briviact | Brivaracetam | SOLUTION;ORAL | 205838 | UCB INC | 08/28/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/205836s017,205837s014,205838s015lbl.pdf#page=18 |
| Briviact | Brivaracetam | TABLET;ORAL | 205836 | UCB INC | 08/28/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/205836s017,205837s014,205838s015lbl.pdf#page=18 |
| Brixadi | Buprenorphine | INJECTION, EXTENDED RELEASE;SUBCUTANEOUS | 210136 | BRAEBURN | 05/23/2023 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/210136s000lbl.pdf#page=52 |
| Brovana | Arformoterol Tartrate | SOLUTION;INHALATION | 021912 | SUNOVION | 05/29/2019 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/021912s013lbl.pdf#page=22 |
| Brynovin | Sitagliptin | SOLUTION;ORAL | 219122 | AZURITY PHARMACEUTICALS, INC | 01/16/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/219122s000lbl.pdf#page=31 |
| Bunavail | Buprenorphine Hydrochloride; Naloxone Hydrochloride | FILM;BUCCAL | 205637 | BDSI | 06/17/2022 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/205637s023s024lbl.pdf#page=33 |
| Butrans | Buprenorphine | FILM, EXTENDED RELEASE;TRANSDERMAL | 021306 | PURDUE PHARMA LP | 12/15/2023 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021306s041lbl.pdf#page=45 |
| Bydureon | Exenatide Synthetic | FOR SUSPENSION, EXTENDED RELEASE;SUBCUTANEOUS | 022200 | ASTRAZENECA AB | 05/28/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/022200s036lbl.pdf#page=38 |
| Bydureon Bcise | Exenatide Synthetic | SUSPENSION, EXTENDED RELEASE;SUBCUTANEOUS | 209210 | ASTRAZENECA AB | 05/28/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/209210s025lbl.pdf#page=37 |
| Bydureon Pen | Exenatide Synthetic | FOR SUSPENSION, EXTENDED RELEASE;SUBCUTANEOUS | 022200 | ASTRAZENECA AB | 05/28/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/022200s036lbl.pdf#page=38 |
| Byetta | Exenatide Synthetic | INJECTABLE;SUBCUTANEOUS | 021773 | ASTRAZENECA AB | 05/28/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/021773s050lbl.pdf#page=33 |
| Byetta | Exenatide Synthetic | INJECTABLE; SUBCUTANEOUS | 021919 | AMYLIN | 10/30/2009 | http://www.fda.gov/downloads/Drugs/DrugSafety/UCM191084.pdf |
| Cambia | Diclofenac Potassium | FOR SOLUTION;ORAL | 022165 | ASSERTIO | 11/21/2024 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/022165s016lbl.pdf#page=22 |
| Camzyos | Mavacamten | CAPSULE;ORAL | 214998 | BRISTOL MYERS SQUIBB | 06/15/2023 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/214998s001lbl.pdf#page=29 |
| Caplyta | Lumateperone Tosylate | CAPSULE;ORAL | 209500 | INTRA-CELLULAR | 11/05/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/209500s016lbl.pdf#page=25 |
| Caprelsa | Vandetanib | TABLET;ORAL | 022405 | GENZYME CORP | 05/14/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/022405s023lbl.pdf#page=21 |
| Carbatrol | Carbamazepine | CAPSULE, EXTENDED RELEASE;ORAL | 020712 | TAKEDA PHARMS USA | 04/11/2023 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/020712s038lbl.pdf#page=23 |
| Cassipa | Buprenorphine Hydrochloride; Naloxone Hydrochloride | FILM;SUBLINGUAL | 208042 | TEVA PHARMS USA | 12/15/2023 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/208042s011lbl.pdf#page=30 |
| Cataflam | Diclofenac Potassium | TABLET;ORAL | 020142 | NOVARTIS | 04/28/2021 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020142s029lbl.pdf#page=19 |
| Cavreto | Pralsetinib | CAPSULE | 213721 | RIGEL PHARMACEUTICALS INC | 12/22/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/213721s016lbl.pdf#page=30 |
| Celebrex | Celecoxib | CAPSULE;ORAL | 020998 | UPJOHN | 11/21/2024 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/020998s058lbl.pdf#page=41 |
| Celebrex | Celecoxib | CAPSULE;ORAL | 021156 | GD SEARLE LLC | 02/04/2011 | http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/020998s033,021156s003MedG.pdf |
| Celexa | Citalopram Hydrobromide | SOLUTION;ORAL | 021046 | FOREST LABS | 12/03/2012 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/020822s042,021046s019lbl.pdf#page=32 |
| Celexa | Citalopram Hydrobromide | TABLET;ORAL | 020822 | ALLERGAN | 08/18/2023 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/020822s054lbl.pdf#page=22 |
| Cellcept | Mycophenolate Mofetil | CAPSULE;ORAL | 050722 | ROCHE PALO | 08/10/2022 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/050722s050,050723s050,050758s048,050759s055lbl.pdf#page=39 |
| Cellcept | Mycophenolate Mofetil | TABLET;ORAL | 050723 | ROCHE PALO | 08/10/2022 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/050722s050,050723s050,050758s048,050759s055lbl.pdf#page=39 |
| Cellcept | Mycophenolate Mofetil Hydrochloride | INJECTABLE;INJECTION | 050758 | ROCHE PALO | 08/10/2022 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/050722s050,050723s050,050758s048,050759s055lbl.pdf#page=39 |
| Cellcept | Mycophenolate Mofetil | FOR SUSPENSION;ORAL | 050759 | ROCHE PALO | 08/10/2022 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/050722s050,050723s050,050758s048,050759s055lbl.pdf#page=39 |
| Celontin | Methsuximide | CAPSULE;ORAL | 010596 | PARKE DAVIS | 06/15/2011 | http://www.fda.gov/downloads/Drugs/DrugSafety/UCM229201.pdf |
| Cerdelga | Eliglustat Tartrate | CAPSULE;ORAL | 205494 | GENZYME CORP | 08/29/2018 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/205494s003lbl.pdf#page=19 |
| Chantix | Varenicline Tartrate | TABLET;ORAL | 021928 | PF PRISM CV | 06/24/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/021928Orig1s051lbl.pdf#page=23 |
| Chlordiazepoxide and Amitriptyline Hydrochloride | Amitriptyline Hydrochloride; Chlordiazepoxide | TABLET;ORAL | 071297 | MYLAN PHARMS INC | 02/05/2021 | http://www.accessdata.fda.gov/drugsatfda_docs/label/2008/071297Orig1s026MG.pdf |
| Cibinqo | Abrocitinib | TABLET; ORAL | 213871 | PFIZER INC | 09/04/2026 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/213871s003lbl.pdf#page=33 |
| Cimzia | Certolizumab Pegol | INJECTABLE; INJECTION | 125160 | UCB INC | 09/23/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/125160s315lbl.pdf#page=42 |
| Cipro | Ciprofloxacin Hydrochloride | TABLET;ORAL | 019537 | BAYER HLTHCARE | 09/20/2024 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/019537s095,020780s050lbl.pdf#page=40 |
| Cipro | Ciprofloxacin | INJECTABLE;INJECTION | 019847 | BAYER HLTHCARE | 03/25/2022 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/019847s063lbl.pdf#page=33 |
| Cipro | Ciprofloxacin | FOR SUSPENSION;ORAL | 020780 | BAYER HLTHCARE | 09/20/2024 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/019537s095,020780s050lbl.pdf#page=40 |
| Cipro in Dextrose 5% in Plastic Container | Ciprofloxacin | INJECTABLE;INJECTION | 019857 | BAYER HLTHCARE | 03/25/2022 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/019857s073lbl.pdf#page=33 |
| Cipro XR | Ciprofloxacin; Ciprofloxacin Hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 021473 | BAYER HLTHCARE | 03/30/2021 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021473s043lbl.pdf#page=30 |
| Citalopram | Citalopram Hydrobromide | CAPSULE; ORAL | 215428 | ALMATICA | 08/18/2023 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/215428s002lbl.pdf#page=24 |
| Clenpiq | Citric Acid; Magnesium Oxide; Sodium Picosulfate | SOLUTION;ORAL | 209589 | FERRING PHARMS INC | 08/29/2023 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/209589s015lbl.pdf#page=14 |
| Clozaril | Clozapine | TABLET;ORAL | 019758 | HLS THERAPEUTICS (USA), INC | 06/13/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/019758s107lbl.pdf#page=29 |
| Codeine Sulfate | Codeine Sulfate | SOLUTION;ORAL | 202245 | HIKMA | 12/15/2023 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/202245s010lbl.pdf#page=30 |
| Codeine Sulfate | Codeine Sulfate | TABLET;ORAL | 022402 | HIKMA | 12/15/2023 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022402s015lbl.pdf#page=29 |
| Colcrys | Colchicine | TABLET;ORAL | 022352 | TAKEDA PHARMS USA | 05/14/2020 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022352s026lbl.pdf#page=25 |
| Colcrys | Colchicine | TABLET; ORAL | 022353 | AR HOLDING CO INC | 10/16/2019 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/022353lbl.pdf#page=19 |
| Columvi | Glofitamab-Gxbm | INJECTABLE;INTRAVENOUS | 761309 | GENETECH | 06/18/2026 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/761309s007lbl.pdf#page=21 |
| Combogesic | Acetaminophen; Ibuprofen | TABLET;ORAL | 209471 | AFT Pharmaceuticals | 11/21/2024 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/209471s001lbl.pdf#page=28 |
| Combunox | Ibuprofen; Oxycodone Hydrochloride | TABLET;ORAL | 021378 | FOREST LABS | 09/02/2010 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021378s006lbl.pdf#page=30 |
| Concerta | Methylphenidate Hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 021121 | JANSSEN PHARMS | 09/23/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/021121s053lbl.pdf#page=30 |
| Consensi | Amlodipine Besylate; Celecoxib | TABLET;ORAL | 210045 | PURPLE BIOTECH | 04/28/2021 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/210045s009lbl.pdf#page=10 |
| Contrave | Bupropion Hydrochloride; Naltrexone Hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 200063 | NALPROPION | 11/05/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/200063s024s026lbl.pdf#page=38 |
| Conzip | Tramadol Hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 022370 | CIPHER PHARMS INC | 12/15/2023 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022370s025lbl.pdf#page=37 |
| Copaxone | Glatiramer Acetate | INJECTABLE;SUBCUTANEOUS | 020622 | TEVA NEUROSCIENCE INC | 01/22/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/020622s118s119lbl.pdf#page=20 |
| Copegus | Ribavirin | TABLET;ORAL | 021511 | ROCHE | 08/11/2015 | http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/021511s029lbl.pdf#page=27 |
| Copiktra | Duvelisib | CAPSULE;ORAL | 211155 | SECURA | 12/17/2021 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/211155s005lbl.pdf#page=28 |
| Cordarone | Amiodarone Hydrochloride | TABLET;ORAL | 018972 | WYETH PHARMS | 10/17/2018 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/018972s054lbl.pdf#page=13 |
| Corlanor | Ivabradine Hydrochloride | TABLET;ORAL | 206143 | AMGEN INC | 08/04/2021 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/206143s008,209964s002lblrpl.pdf#page=24 |
| Corlanor | Ivabradine | SOLUTION;ORAL | 209964 | AMGEN INC | 08/04/2021 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/206143s008,209964s002lblrpl.pdf#page=24 |
| Cosentyx | Secukinumab | INJECTABLE;SUBCUTANEOUS, INTRAVENOUS | 761349 | NOVARTIS PHARMACEUTICALS CORPORATION | 10/16/2026 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/761349s013lbl.pdf#page=37 |
| Cosentyx | Secukinumab | INJECTABLE;INJECTION | 125504 | NOVARTIS PHARMS CORP | 10/16/2026 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/125504s099lbl.pdf#page=37 |
| Cotempla XR-Odt | Methylphenidate | TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE;ORAL | 205489 | NEOS THERAPS INC | 09/23/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/205489s021lbl.pdf#page=24 |
| Coumadin | Warfarin Sodium | INJECTABLE;INJECTION | 009218 | BRISTOL MYERS SQUIBB | 08/14/2017 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/009218s118lbl.pdf#page=30 |
| Coumadin | Warfarin Sodium | TABLET;ORAL | 009218 | BRISTOL MYERS SQUIBB | 08/14/2017 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/009218s118lbl.pdf#page=30 |
| Coxanto | Oxaprozin | CAPSULE;ORAL | 217927 | SOLUBIOMIX | 11/21/2024 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/217927s002lbl.pdf#page=24 |
| Creon | Pancrelipase (Amylase;Lipase;Protease) | CAPSULE, DELAYED RELEASE;ORAL | 020725 | ABBVIE | 06/02/2024 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020725s028lbl.pdf#page=16 |
| Cyltezo | Adalimumab-Adbm | INJECTABLE;INJECTION | 761058 | BOEHRINGER INGELHEIM | 10/16/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/761058s035lbl.pdf#page=38 |
| Cymbalta | Duloxetine Hydrochloride | CAPSULE, DELAYED REL PELLETS;ORAL | 021427 | LILLY | 08/18/2023 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021427s055s057lbl.pdf#page=38 |
| Daliresp | Roflumilast | TABLET;ORAL | 022522 | ASTRAZENECA | 01/23/2018 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/022522s009lbl.pdf#page=17 |
| Dalmane | Flurazepam Hydrochloride | CAPSULE;ORAL | 016721 | VALEANT PHARM INTL | 03/27/2009 | http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/016721s077lbl.pdf |
| Danziten | Nilotinib | TABLET | 219293 | AZURITY PHARMACEUTICALS INC. | 04/15/2026 | http://www.accessdata.fda.gov/drugsatfda_docs/label/2026/219293s006lbl.pdf#page=39 |
| Daraxonrasib | Daraxonrasib | TABLET | 220910 | REVOLUTION MEDICINES INC | 09/01/2026 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/220910Orig1s000lbl.pdf#page=20 |
| Darvocet-N 100 | Acetaminophen; Propoxyphene Napsylate | TABLET;ORAL | 017122 | XANODYNE PHARM | 09/25/2009 | http://www.fda.gov/downloads/Drugs/DrugSafety/UCM187067.pdf |
| Darvocet-N 50 | Acetaminophen; Propoxyphene Napsylate | TABLET;ORAL | 017122 | XANODYNE PHARM | 09/25/2009 | http://www.fda.gov/downloads/Drugs/DrugSafety/UCM187067.pdf |
| Darvon | Propoxyphene Hydrochloride | CAPSULE;ORAL | 010997 | XANODYNE PHARM | 09/25/2009 | http://www.fda.gov/downloads/Drugs/DrugSafety/UCM187068.pdf |
| Darvon-N | Propoxyphene Napsylate | TABLET;ORAL | 016862 | XANODYNE PHARM | 09/25/2009 | http://www.fda.gov/downloads/Drugs/DrugSafety/UCM187068.pdf |
| Datroway | Datopotamab Deruxtecan-Dlnk | INJECTABLE;INTRAVENOUS | 761394 | DAIICHI SANKYO COMPANY, LTD | 01/17/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/761394s000lbl.pdf#page=16 |
| Datroway | Datopotamab Deruxtecan-Dlnk | INJECTABLE:INTRAVENOUS | 761464 | DAIICHI SANKYO, INC. | 06/23/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/761464s000lbl.pdf#page=21 |
| Daurismo | Glasdegib Maleate | TABLET;ORAL | 210656 | PFIZER | 03/27/2023 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/210656s005lbl.pdf#page=20 |
| Daxxify | Daxibotulinumtoxina-Lanm | INJECTABLE;INTRAMUSCULAR | 761127 | REVANCE THERAPEUTICS, INC | 08/11/2023 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761127s002lbl.pdf#page=16 |
| Daypro | Oxaprozin | TABLET;ORAL | 018841 | PFIZER | 11/21/2024 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/018841s036lbl.pdf#page=25 |
| Daypro Alta | Oxaprozin Potassium | TABLET;ORAL | 020776 | PFIZER | 11/21/2024 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/020776s013lbl.pdf#page=22 |
| Daytrana | Methylphenidate | SYSTEM;TRANSDERMAL | 021514 | NOVEN PHARMACEUTICALS, INC | 11/29/2024 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/021514s039lbl.pdf#page=24 |
| Daytrana | Methylphenidate | FILM, EXTENDED RELEASE;TRANSDERMAL | 021514 | NOVEN PHARMS INC | 09/23/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/021514s043lbl.pdf#page=25 |
| Dayvigo | Lemborexant | TABLET;ORAL | 212028 | EISAI INC | 02/19/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/212028s011lbl.pdf#page=20 |
| Demerol | Meperidine Hydrochloride | TABLET;ORAL | 005010 | VALIDUS PHARMS | 12/22/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/005010s062lbl.pdf#page=29 |
| Demerol | Meperidine Hydrochloride | INJECTABLE;INJECTION | 005010 | VALIDUS PHARMS | 12/22/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/005010s062lbl.pdf#page=29 |
| Demerol | Meperidine Hydrochloride | SYRUP;ORAL | 005010 | VALIDUS PHARMS | 12/22/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/005010s062lbl.pdf#page=29 |
| Depakene | Valproic Acid | CAPSULE;ORAL | 018081 | ABBVIE | 05/19/2020 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/018081s070,018082s053lbl.pdf#page=41 |
| Depakene | Valproic Acid | SYRUP;ORAL | 018082 | ABBVIE | 05/19/2020 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/018081Orig1s068%20018082Orig1s051lbl.pdf#page=38 |
| Depakote | Divalproex Sodium | CAPSULE, DELAYED REL PELLETS;ORAL | 019680 | ABBVIE | 01/23/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/019680s056lbl.pdf#page=42 |
| Depakote | Divalproex Sodium | TABLET, DELAYED RELEASE;ORAL | 018723 | ABBVIE | 03/31/2026 | http://www.accessdata.fda.gov/drugsatfda_docs/label/2026/018723s073lbl.pdf#page=50 |
| Depakote ER | Divalproex Sodium | TABLET, EXTENDED RELEASE;ORAL | 021168 | ABBVIE | 01/23/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/021168s049lbl.pdf#page=140 |
| Descovy | Emtricitabine; Tenofovir Alafenamide Fumarate | TABLET;ORAL | 208215 | GILEAD SCIENCES INC | 06/20/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/208215s023s025lbl.pdf#page=43 |
| Desoxyn | Methamphetamine Hydrochloride | TABLET;ORAL | 005378 | RECORDATI RARE | 10/13/2023 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/005378s038lbl.pdf#page=12 |
| Desoxyn | Methamphetamine Hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 005378 | RECORDATI RARE | 09/24/2024 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/005378s032lbl.pdf#page=17 |
| Desvenlafaxine | Desvenlafaxine Fumarate | TABLET, EXTENDED RELEASE;ORAL | 205208 | TEVA PHARMS USA | 07/18/2014 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/205208Orig1s001lbl.pdf#page=23 |
| Desvenlafaxine | Desvenlafaxine | TABLET, EXTENDED RELEASE;ORAL | 204150 | ALEMBIC PHARMS LTD | 08/18/2023 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/204150s020lbl.pdf#page=33 |
| Desyrel | Trazodone Hydrochloride | TABLET;ORAL | 018207 | PRAGMA | 10/18/2018 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/018207s032lbl.pdf#page=13 |
| Desyrel | Trazodone Hydrochloride | TABLET;ORAL | 018207 | PRAGMA | 10/18/2018 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/018207s033lbl.pdf#page=14 |
| Dexedrine | Dextroamphetamine Sulfate | CAPSULE, EXTENDED RELEASE;ORAL | 017078 | IMPAX LABS INC | 09/23/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/017078s059lbl.pdf#page=14 |
| Dexilant | Dexlansoprazole | CAPSULE, DELAYED RELEASE;ORAL | 022287 | TAKEDA PHARMS USA | 07/18/2023 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022287s038lbl.pdf#page=24 |
| Dextroamphetamine Sulfate | Dextroamphetamine Sulfate | SOLUTION;ORAL | 040776 | OUTLOOK PHARMS | 01/04/2017 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/40776MG.pdf#page=7 |
| Diacomit | Stiripentol | CAPSULE;ORAL | 206709 | BIOCODEX SA | 04/16/2026 | http://www.accessdata.fda.gov/drugsatfda_docs/label/2026/206709s006lbl.pdf#page=17 |
| Diacomit | Stiripentol | FOR SUSPENSION;ORAL | 207223 | BIOCODEX SA | 08/20/2018 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/206709s000,207223s000lbl.pdf#page=17 |
| Dilantin | Phenytoin Sodium | CAPSULE;ORAL | 084349 | UPJOHN | 09/07/2022 | http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/084349s088lbl.pdf#page=21 |
| Dilantin | Phenytoin | TABLET, CHEWABLE;ORAL | 084427 | PHARMACIA | 10/22/2021 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/084427s039s041lbl.pdf#page=17 |
| Dilantin-125 | Phenytoin | SUSPENSION;ORAL | 008762 | UPJOHN | 03/03/2022 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/008762s066lbl.pdf#page=19 |
| Dilantin-30 | Phenytoin | SUSPENSION;ORAL | 008762 | UPJOHN | 03/03/2022 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/008762s066lbl.pdf#page=19 |
| Dilaudid | Hydromorphone Hydrochloride | SOLUTION;ORAL | 019891 | RHODES PHARMS | 12/15/2023 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/019891s031,019892s041lbl.pdf#page=32 |
| Dilaudid | Hydromorphone Hydrochloride | TABLET;ORAL | 019892 | RHODES PHARMS | 12/15/2023 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/019891s031,019892s041lbl.pdf#page=32 |
| Dolophine Hydrochloride | Methadone Hydrochloride | SYRUP;ORAL | 006134 | HIKMA | 06/02/2021 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/006134s050lbl.pdf#page=36 |
| Dolophine Hydrochloride | Methadone Hydrochloride | TABLET;ORAL | 006134 | HIKMA | 06/02/2021 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/006134s050lbl.pdf#page=36 |
| Doral | Quazepam | TABLET;ORAL | 018708 | GALT PHARMS | 01/13/2023 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/018708s029lbl.pdf#page=11 |
| Dotarem | Gadoterate Meglumine | SOLUTION;INTRAVENOUS | 204781 | GUERBET | 03/05/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/204781s015lbl.pdf#page=30 |
| Drizalma Sprinkle | Duloxetine Hydrochloride | CAPSULE, DELAYED REL PELLETS;ORAL | 212516 | SUN PHARMA GLOBAL | 08/18/2023 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/212516s005lbl.pdf#page=45 |
| Droxia | Hydroxyurea | CAPSULE;ORAL | 016295 | BRISTOL MYERS SQUIBB | 11/28/2023 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/016295s058lbl.pdf#page=16 |
| Duetact | Glimepiride; Pioglitazone Hydrochloride | TABLET;ORAL | 021925 | TAKEDA PHARMS USA | 12/21/2017 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021925s017lbl.pdf#page=39 |
| Duexis | Famotidine; Ibuprofen | TABLET;ORAL | 022519 | HORIZON | 11/21/2024 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/022519s014lbl.pdf#page=25 |
| Duragesic-100 | Fentanyl | FILM, EXTENDED RELEASE;TRANSDERMAL | 019813 | JANSSEN PHARMS | 03/04/2021 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/019813s081lbl.pdf#page=52 |
| Duragesic-12 | Fentanyl | FILM, EXTENDED RELEASE;TRANSDERMAL | 019813 | JANSSEN PHARMS | 03/04/2021 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/019813s081lbl.pdf#page=52 |
| Duragesic-25 | Fentanyl | FILM, EXTENDED RELEASE;TRANSDERMAL | 019813 | JANSSEN PHARMS | 03/04/2021 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/019813s081lbl.pdf#page=52 |
| Duragesic-37 | Fentanyl | FILM, EXTENDED RELEASE;TRANSDERMAL | 019813 | JANSSEN PHARMS | 03/04/2021 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/019813s081lbl.pdf#page=52 |
| Duragesic-50 | Fentanyl | FILM, EXTENDED RELEASE;TRANSDERMAL | 019813 | JANSSEN PHARMS | 03/04/2021 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/019813s081lbl.pdf#page=52 |
| Duragesic-75 | Fentanyl | FILM, EXTENDED RELEASE;TRANSDERMAL | 019813 | JANSSEN PHARMS | 03/04/2021 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/019813s081lbl.pdf#page=52 |
| Duzallo | Allopurinol; Lesinurad | TABLET;ORAL | 209203 | IRONWOOD PHARMS INC | 08/18/2017 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/209203s000lbl.pdf#page=27 |
| Dyanavel XR | Amphetamine | SUSPENSION, EXTENDED RELEASE;ORAL | 208147 | TRIS PHARMA INC | 09/23/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/208147s018,210526s010lbl.pdf#page=21 |
| Dyanavel XR 10 | Amphetamine; Amphetamine Aspartate/Dextroamphetamine Sulfate | TABLET, EXTENDED RELEASE;ORAL | 210526 | TRIS PHARMA INC | 09/23/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/208147s018,210526s010lbl.pdf#page=21 |
| Dyanavel XR 15 | Amphetamine; Amphetamine Aspartate/Dextroamphetamine Sulfate | TABLET, EXTENDED RELEASE;ORAL | 210526 | TRIS PHARMA INC | 09/23/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/208147s018,210526s010lbl.pdf#page=21 |
| Dyanavel XR 20 | Amphetamine; Amphetamine Aspartate/Dextroamphetamine Sulfate | TABLET, EXTENDED RELEASE;ORAL | 210526 | TRIS PHARMA INC | 09/23/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/208147s018,210526s010lbl.pdf#page=21 |
| Dyanavel XR 5 | Amphetamine; Amphetamine Aspartate/Dextroamphetamine Sulfate | TABLET, EXTENDED RELEASE;ORAL | 210526 | TRIS PHARMA INC | 09/23/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/208147s018,210526s010lbl.pdf#page=21 |
| Dysport | Abobotulinumtoxina | INJECTABLE; INJECTION | 125274 | IPSEN BIOPHARM LTD | 09/21/2023 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/125274s125lbl.pdf#page=30 |
| EC-Naprosyn | Naproxen | TABLET, DELAYED RELEASE;ORAL | 020067 | ATNAHS PHARMA US | 11/21/2024 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/017581s117,018164s067,020067s026lbl.pdf |
| Eculizumab | Eculizumab | SOLUTION | 761333 | KAI PHARMACEUTICALS INC | 11/24/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/761333s005lbl.pdf#page=31 |
| Eculizumab-Aagh | Eculizumab-Aagh | INJECTABLE;INTRAVENOUS | 761340 | SAMSUNG BIOEPIS CO | 11/28/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/761340s000_Orig2lbl.pdf#page=31 |
| Edluar | Zolpidem Tartrate | TABLET;SUBLINGUAL | 021997 | MYLAN SPECIALITY LP | 08/18/2019 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021997s011lbl.pdf#page=23 |
| Effexor | Venlafaxine Hydrochloride | TABLET;ORAL | 020151 | WYETH PHARMS INC | 12/12/2012 | http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/020151s031s055s058s060lbl.pdf#page=34 |
| Effexor XR | Venlafaxine Hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 020699 | UPJOHN | 08/18/2023 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/020699s118lbl.pdf#page=41 |
| Effient | Prasugrel Hydrochloride | TABLET;ORAL | 022307 | DAIICHI SANKYO INC | 12/22/2020 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022307s018lbl.pdf#page=21 |
| Elepsia XR | Levetiracetam | TABLET, EXTENDED RELEASE;ORAL | 204417 | TRIPOINT | 03/12/2024 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/204417s004lbl.pdf#page=25 |
| Elidel | Pimecrolimus | CREAM;TOPICAL | 021302 | BAUSCH | 06/09/2016 | http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088587.pdf |
| Eliquis | Apixaban | TABLET;ORAL | 202155 | BRISTOL MYERS SQUIBB | 10/12/2021 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/202155s034lbl.pdf#page=38 |
| Elmiron | Pentosan Polysulfate Sodium | CAPSULE;ORAL | 020193 | JANSSEN PHARMS | 03/12/2021 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020193s015lbl.pdf#page=11 |
| Elrexfio | Elranatamab-Bcmm | INJECTABLE; SUBCUTANEOUS | 761345 | PFIZER | 02/19/2026 | http://www.accessdata.fda.gov/drugsatfda_docs/label/2026/761345s007lbl.pdf#page=22 |
| Elucirem | Gadopiclenol | INJECTABLE;INTRAVENOUS | 216986 | LIEBEL-FLARSHEIM COMPANY | 02/20/2026 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/216986s009lbl.pdf#page=20 |
| Elyxyb | Celecoxib | SOLUTION;ORAL | 212157 | BDSI | 11/21/2024 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/212157s003lbl.pdf#page=26 |
| Embeda | Morphine Sulfate; Naltrexone Hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 022321 | ALPHARMA PHARMS | 10/07/2019 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022321s030lbl.pdf#page=30 |
| Empavel | Pegcetacoplan | INJECTABLE;SUBCUTANEOUS | 215014 | APELLIS PHARMACEUTICALS | 06/12/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/215014s010lbl.pdf#page=19 |
| Emrelis | Teliosotuzumab Vedotin-Tllv | INJECTABLE;INTRAVENOUS | 761384 | ABBVIE | 05/14/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/761384s000lbl.pdf#page=19 |
| Emsam | Selegiline | FILM, EXTENDED RELEASE;TRANSDERMAL | 021336 | SOMERSET | 07/14/2017 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021336s014lbl.pdf#page=34 |
| Enbrel | Etanercept | VIAL; SUBCUTANEOUS | 103795 | IMMUNEX | 01/30/2026 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/103795s5605lbl.pdf#page=33 |
| Enbrel | Etanercept | SYRINGE | 103795 | IMMUNEX | 01/30/2026 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/103795s5605lbl.pdf#page=33 |
| Enhertu | Fam-Trastuzumab Deruxtecan-Nxki | INJECTABLE;INJECTION | 761139 | DAIICHI SANKYO | 05/18/2026 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/761139s041s043lbl.pdf#page=65 |
| Enjaymo | Sutimlimab-Jome | INJECTABLE;INJECTION | 761164 | NULL | 02/08/2024 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761164s000lbl.pdf#page=13 |
| Enspryng | Satralizumab-Mwge | INJECTABLE;SUBCUTANEOUS | 761149 | GENETECH, INC | 10/16/2026 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/761149s008lbl.pdf#page=25 |
| Entyvio | Vedolizumab | INJECTABLE;INTRAVENOUS | 761133 | TAKEDA PHARMACEUTICALS USA INC | 04/18/2024 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761133s000lbl.pdf#page=23 |
| Entyvio | Vedolizumab | INJECTABLE;SUBCUTANEOUS | 761133 | TAKEDA PHARMACEUTICALS USA INC | 04/18/2024 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761133s000lbl.pdf#page=23 |
| Entyvio | Vedolizumab | INJECTABLE;INJECTION | 125476 | TAKEDA PHARMS USA | 04/18/2024 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/125476s038s039lbl.pdf#page=20 |
| Entyvio Pen | Vedolizumab | INJECTABLE;SUBCUTANEOUS | 761133 | TAKEDA PHARMACEUTICALS USA INC | 04/18/2024 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761133s000lbl.pdf#page=23 |
| Envarsus XR | Tacrolimus | TABLET, EXTENDED RELEASE;ORAL | 206406 | VELOXIS PHARMS INC | 04/08/2024 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/206406s010lbl.pdf#page=29 |
| Eovist | Gadoxetate Disodium | SOLUTION;INTRAVENOUS | 022090 | BAYER HLTHCARE | 03/05/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/022090s027lbl.pdf#page=15 |
| Epidiolex | Cannabidiol | SOLUTION;ORAL | 210365 | GW RES LTD | 06/26/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/210365s023lbl.pdf#page=26 |
| Epkinly | Epcoritamab-Bysp | INJECTABLE;SUBCUTANEOUS | 761324 | GENMAB US | 03/27/2026 | http://www.accessdata.fda.gov/drugsatfda_docs/label/2026/761324s010lbl.pdf#page=45 |
| Epogen | Epoetin Alfa | VIAL; SINGLE-USE | 103234 | AMGEN | 04/30/2024 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/103234s5363s5366lbl.pdf#page=27 |
| Eprontia | Topiramate | SOLUTION | 214679 | AZURITY PHARMACEUTICALS INC | 03/06/2026 | http://www.accessdata.fda.gov/drugsatfda_docs/label/2026/214679s012lbl.pdf#page=51 |
| Epzicom | Abacavir Sulfate; LAmivudine | TABLET;ORAL | 021652 | VIIV HLTHCARE | 12/10/2021 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021652s029lbl.pdf#page=28 |
| Equetro | Carbamazepine | CAPSULE, EXTENDED RELEASE;ORAL | 021710 | VALIDUS PHARMS | 10/14/2022 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021710s018lbl.pdf#page=27 |
| Erelzi | Etanercept-Szzs | INJECTABLE; INJECTION | 761042 | SANDOZ | 11/10/2022 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761042s018lbl.pdf#page=41 |
| Erivedge | Vismodegib | CAPSULE;ORAL | 203388 | GENENTECH | 03/27/2023 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/203388s017lbl.pdf#page=15 |
| Escitalopram | Escitalopram | CAPSULE | 219130 | ALMATICA PHARMA LLC | 08/29/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/219130s000lbl.pdf#page=28 |
| Esomeprazole Strontium | Esomeprazole Strontium | CAPSULE, DELAYED RELEASE;ORAL | 202342 | BELCHER | 03/04/2022 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/202342s007lbl.pdf#page=29 |
| Estazolam | Estazolam | TABLET;ORAL | 074921 | MAYNE PHARMA | 02/05/2021 | http://www.fda.gov/downloads/Drugs/DrugSafety/UCM359235.pdf |
| Eticovo | Etanercept-Ykro | INJECTABLE;INJECTION | 761066 | SAMSUNG BIOEPIS CO LTD | 05/03/2024 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761066s000lbl.pdf#page=31 |
| Evekeo ODT | Amphetamine Sulfate | TABLET, ORALLY DISINTEGRATING;ORAL | 209905 | ARBOR PHARMS LLC | 10/13/2023 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/209905s004lbl.pdf#page=16 |
| Evenity | Romosozumab-Aqqg | INJECTABLE;INJECTION | 761062 | AMGEN INC | 12/20/2019 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761062s000lbl.pdf#page=19 |
| Evista | Raloxifene Hydrochloride | TABLET; ORAL | 022042 | LILLY | 09/13/2007 | http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088593.pdf |
| Evista | Raloxifene Hydrochloride | TABLET;ORAL | 020815 | LILLY | 06/27/2018 | http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088593.pdf |
| Exalgo | Hydromorphone Hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 021217 | SPECGX LLC | 10/07/2019 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021217s025lbl.pdf#page=31 |
| Exjade | Deferasirox | TABLET, FOR SUSPENSION;ORAL | 021882 | NOVARTIS | 07/23/2020 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021882s033lbl.pdf#page=28 |
| Extavia | Interferon Beta-1b | INJECTABLE; SUBCUTANEOUS | 125290 | NOVARTIS PHARMS | 07/28/2023 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/125290s074lbl.pdf#page=16 |
| Fabhalta | Iptacopan | CAPSULE;ORAL | 218276 | NOVARTIS PHARMACEUTICALS | 07/21/2026 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/218276s007lbl.pdf#page=22 |
| Factive | Gemifloxacin Mesylate | TABLET;ORAL | 021158 | LG CHEM LTD | 07/26/2016 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021158s026lbl.pdf#page=30 |
| Farxiga | Dapagliflozin | TABLET;ORAL | 202293 | ASTRAZENECA AB | 06/12/2024 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/202293s030lbl.pdf#page=53 |
| Farydak | Panobinostat LActate | CAPSULE;ORAL | 205353 | SECURA | 06/06/2016 | http://www.fda.gov/downloads/Drugs/DrugSafety/UCM436377.pdf |
| Felbatol | Felbamate | TABLET;ORAL | 020189 | MYLAN SPECIALITY LP | 08/31/2012 | http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/020189s027mg.pdf |
| Felbatol | Felbamate | SUSPENSION;ORAL | 020189 | MYLAN SPECIALITY LP | 08/31/2012 | http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/020189s027mg.pdf |
| Feldene | Piroxicam | CAPSULE;ORAL | 018147 | PFIZER | 11/21/2024 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/018147s050lbl.pdf#page=21 |
| Fensolvi Kit | Leuprolide Acetate | POWDER;SUBCUTANEOUS | 213150 | TOLMAR | 09/23/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/213150s011lbl.pdf#page=16 |
| Fentanyl Citrate | Fentanyl Citrate | TROCHE/LOZENGE;TRANSMUCOSAL | 077312 | PAR PHARM | 09/07/2017 | http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/077312MedGuide.pdf |
| Fentanyl Citrate | Fentanyl Citrate | TROCHE/LOZENGE;TRANSMUCOSAL | 078907 | SPECGX LLC | 12/03/2021 | http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/078907MedGuide.pdf |
| Fentora | Fentanyl Citrate | TABLET;BUCCAL, SUBLINGUAL | 021947 | CEPHALON | 12/15/2023 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021947s043lbl.pdf#page=43 |
| Ferriprox | Deferiprone | TABLET;ORAL | 212269 | CHIESI | 11/30/2021 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/212269s003lbl.pdf#page=17 |
| Ferriprox | Deferiprone | TABLET;ORAL | 021825 | CHIESI | 11/30/2021 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021825s010lbl.pdf#page=17 |
| Ferriprox | Deferiprone | SOLUTION;ORAL | 208030 | CHIESI | 11/30/2021 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/208030s007lbl.pdf#page=13 |
| Fetzima | Levomilnacipran Hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 204168 | ALLERGAN | 04/19/2024 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/204168s011lbl.pdf#page=29 |
| Filspari | Sparsentan | TABLET;ORAL | 216403 | TRAVERE THERAPEUTICS | 04/13/2026 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/216403s006lbl.pdf#page=28 |
| Fintepla | Fenfluramine Hydrochloride | SOLUTION;ORAL | 212102 | ZOGENIX INC | 10/15/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/212102s017lbl.pdf#page=30 |
| Fioricet W/ Codeine | Acetaminophen; Butalbital; Caffeine; Codeine Phosphate | CAPSULE;ORAL | 020232 | ACTAVIS LABS UT INC | 12/15/2023 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/020232s047lbl.pdf#page=44 |
| Fiorinal W/Codeine | Aspirin; Butalbital; Caffeine; Codeine Phosphate | CAPSULE;ORAL | 019429 | ALLERGAN | 04/28/2021 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/019429s043lbl.pdf#page=39 |
| Firdapse | Amifampridine Phosphate | TABLET;ORAL | 208078 | CATALYST PHARMS | 07/17/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/208078s015lbl.pdf#page=12 |
| Flector | Diclofenac Epolamine | SYSTEM;TOPICAL | 021234 | INST BIOCHEM | 11/21/2024 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/021234s024lbl.pdf#page=24 |
| Flowtuss | Guaifenesin; Hydrocodone Bitartrate | SOLUTION;ORAL | 022424 | BKK PHARMS | 12/22/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/022424s004lbl.pdf#page=23 |
| Floxin | Ofloxacin | TABLET;ORAL | 019735 | JANSSEN PHARMS | 02/25/2011 | http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/019735s061MedG.pdf |
| Fluoxetine Hydrochloride | Fluoxetine Hydrochloride | TABLET;ORAL | 202133 | ALMATICA | 08/18/2023 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/202133s009s016lbl.pdf#page=36 |
| Focalin | Dexmethylphenidate Hydrochloride | TABLET;ORAL | 021278 | NOVARTIS | 10/13/2023 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021278s028s031lbl.pdf#page=17 |
| Focalin XR | Dexmethylphenidate Hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 021802 | NOVARTIS | 09/23/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/021802s045lbl.pdf#page=23 |
| Foradil | Formoterol Fumarate | POWDER;INHALATION | 020831 | NOVARTIS | 03/02/2016 | http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088602.pdf |
| Foradil Certihaler | Formoterol Fumarate | POWDER;INHALATION | 021592 | NOVARTIS | 06/02/2010 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021592s003lbl.pdf#page=35 |
| Forfivo XL | Bupropion Hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 022497 | ALMATICA | 11/05/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/022497s018lbl.pdf#page=32 |
| Forteo | Teriparatide | SOLUTION;SUBCUTANEOUS | 021318 | LILLY | 08/11/2026 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/021318s059lbl.pdf#page=17 |
| Fortesta | Testosterone | GEL, METERED;TRANSDERMAL | 021463 | ENDO PHARMS | 07/11/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/021463s029lbl.pdf#page=23 |
| Fosamax | Alendronate Sodium | SOLUTION;ORAL | 021575 | MERCK | 11/30/2015 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/020560s068,021575s024lbl.pdf#page=24 |
| Fosamax | Alendronate Sodium | TABLET;ORAL | 020560 | MERCK AND CO INC | 02/03/2026 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/020560s073lbl.pdf#page=25 |
| Fosamax Plus D | Alendronate Sodium; Cholecalciferol | TABLET;ORAL | 021762 | ORGANON | 02/03/2026 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/021762s027lbl.pdf#page=24 |
| Fosamax Plus D | Alendronate Sodium; Cholecalciferol | TABLET;ORAL | 021762 | ORGANON | 08/16/2019 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021762s022lbl.pdf#page=23 |
| Foscarbidopa and Foslevodopa | Foscarbidopa, Foslevodopa | INJECTION, SOLUTION | 216962 | ABBVIE INC | 03/19/2026 | http://www.accessdata.fda.gov/drugsatfda_docs/label/2026/216962s007lbl.pdf#page=21 |
| Fosrenol | Lanthanum Carbonate | POWDER;ORAL | 204734 | TAKEDA PHARMS USA | 08/29/2024 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/204734s007,021468s025lbl.pdf#page=12 |
| Fosrenol | Lanthanum Carbonate | TABLET, CHEWABLE;ORAL | 021468 | TAKEDA PHARMS USA | 08/29/2024 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/204734s007,021468s025lbl.pdf#page=12 |
| Foundayo | Orforglipron | TABLET | 220934 | ELI LILLY AND COMPANY | 08/04/2026 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/220934s003lbl.pdf#page=24 |
| Fycompa | Perampanel | TABLET;ORAL | 202834 | EISAI INC | 05/30/2019 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/202834s016,208277s004lbl.pdf#page=24 |
| Fycompa | Perampanel | SUSPENSION;ORAL | 208277 | EISAI INC | 02/23/2021 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/208277s005lbl.pdf#page=24 |
| Gabitril | Tiagabine Hydrochloride | TABLET;ORAL | 020646 | CEPHALON | 08/09/2016 | http://www.fda.gov/downloads/Drugs/DrugSafety/UCM229203.pdf |
| Gadavist | Gadobutrol | SOLUTION;INTRAVENOUS | 201277 | BAYER HLTHCARE | 02/13/2026 | http://www.accessdata.fda.gov/drugsatfda_docs/label/2026/201277s025lbl.pdf#page=23 |
| Gattex Kit | Teduglutide Recombinant | POWDER;SUBCUTANEOUS | 203441 | NPS PHARMS INC | 09/05/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/203441s024lbl.pdf#page=36 |
| Gilenya | Fingolimod Hydrochloride | CAPSULE;ORAL | 022527 | NOVARTIS | 08/22/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/022527s044lbl.pdf#page=26 |
| Gimoti | Metoclopramide Hydrochloride | SPRAY, METERED;NASAL | 209388 | EVOKE PHARMA INC | 01/14/2021 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/209388s001lbl.pdf#page=17 |
| Gloperba | Colchicine | SOLUTION;ORAL | 210942 | ROMEG | 08/28/2024 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/210942s002lbl.pdf#page=14 |
| Glyxambi | Empagliflozin; Linagliptin | TABLET;ORAL | 206073 | BOEHRINGER INGELHEIM | 10/24/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/206073s044lbl.pdf#page=34 |
| Golytely | Polyethylene Glycol 3350; Potassium Chloride; Sodium Bicarbonate; Sodium Chloride; Sodium Sulfate Anhydrous | FOR SOLUTION;ORAL | 019011 | BRAINTREE | 05/14/2021 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/019011s033lbl.pdf#page=9 |
| Gralise | Gabapentin | TABLET;ORAL | 022544 | ALMATICA | 04/18/2023 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022544Orig1s029lbl.pdf#page=21 |
| H.P. Acthar Gel | Repository Corticotropin | INJECTABLE; INJECTION | 022432 | QUESTCOR PHARMA | 10/15/2010 | http://www.fda.gov/downloads/Drugs/DrugSafety/UCM231714.pdf |
| Hadlima | Adalimumab-Bwwd | INJECTABLE;INJECTION | 761059 | SAMSUNG BIOEPIS CO LTD | 10/17/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/761059s032lbl.pdf#page=45 |
| Halcion | Triazolam | TABLET;ORAL | 017892 | PFIZER | 01/13/2023 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/017892s057lbl.pdf#page=20 |
| Halflytely | Bisacodyl; Polyethylene Glycol 3350; Potassium Chloride; Sodium Bicarbonate; Sodium Chloride | FOR SOLUTION, TABLET, DELAYED RELEASE;ORAL | 021551 | BRAINTREE | 06/03/2013 | http://www.fda.gov/downloads/Drugs/DrugSafety/UCM220644.pdf |
| Hemangeol | Propranolol Hydrochloride | SOLUTION;ORAL | 205410 | PIERRE FABRE DERMA | 06/22/2021 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/205410s006lbl.pdf#page=11 |
| Hemlibra | Emicizumab | INJECTABLE;INJECTION | 761083 | GENENTECH INC | 07/08/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/761083s020lbl.pdf#page=25 |
| Hibsago | Bepirovirsen | INJECTION, SOLUTION | 221276 | GLAXOSMITHKLINE LLC | 10/21/2026 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/221276Orig1s000lbl.pdf#page=33 |
| Horizant | Gabapentin Enacarbil | TABLET, EXTENDED RELEASE;ORAL | 022399 | ARBOR PHARMS LLC | 04/17/2020 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022399s010lbl.pdf#page=27 |
| Hulio | Adalimumab-Fkjp | INJECTABLE;INJECTION | 761154 | MYLAN PHARMS INC | 02/05/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/761154s009lbl.pdf#page=45 |
| Humira | Adalimumab | SYRINGE | 125057 | ABBVIE INC | 07/16/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/125057s424lbl.pdf#page=59 |
| Humira | Adalimumab | VIAL | 125057 | ABBVIE INC | 07/16/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/125057s424lbl.pdf#page=59 |
| Hycodan | Homatropine METhylbromide; Hydrocodone Bitartrate | TABLET;ORAL | 005213 | GENUS | 12/15/2023 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/005213s046lbl.pdf#page=27 |
| Hycodan | Homatropine METhylbromide; Hydrocodone Bitartrate | SYRUP;ORAL | 005213 | GENUS | 12/15/2023 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/005213s046lbl.pdf#page=27 |
| Hycofenix | Hydrocodone Bitartrate;Pseudoephedrine Hydrochloride;Guaifenesin | SOLUTION;ORAL | 022279 | BKK PHARMACEUTICALS | 12/22/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/022279s004lbl.pdf#page=26 |
| Hydromorphone Hydrochloride | Hydromorphone Hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 204278 | PADAGIS US | 03/04/2021 | http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/204278Orig1s000MG.pdf |
| Hyrimoz | Adalimumab-Adaz | INJECTABLE;INJECTION | 761071 | SANDOZ INC | 10/16/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/761071s031lbl.pdf#page=50 |
| Hysingla ER | Hydrocodone Bitartrate | TABLET, EXTENDED RELEASE;ORAL | 206627 | PURDUE PHARMA LP | 12/15/2023 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/206627s015lbl.pdf#page=40 |
| Ibsrela | Tenapanor Hydrochloride | TABLET;ORAL | 211801 | ARDELYX INC | 05/20/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/211801s014lbl.pdf#page=14 |
| Iclusig | Ponatinib Hydrochloride | TABLET;ORAL | 203469 | TAKEDA PHARMS USA | 10/10/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/203469s038lbl.pdf#page=43 |
| Idacio | Adalimumab-Aacf | INJECTABLE;SUBCUTANEOUS | 761255 | FRESENIUS KABI USA | 06/04/2024 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761255s004lbl.pdf#page=48 |
| Idhifa | Enasidenib Mesylate | TABLET;ORAL | 209606 | CELGENE CORP | 01/16/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/209606s007lbl.pdf#page=18 |
| Ilaris | Canakinumab | INJECTABLE; SUBCUTANEOUS | 125319 | NOVARTIS PHARMS | 08/25/2023 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/125319s107lbl.pdf#page=24 |
| Ilumya | Tildrakizumab-Asmn | INJECTABLE;INJECTION | 761067 | SUN PHARMA GLOBAL | 07/21/2026 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/761067s007lbl.pdf#page=15 |
| Imdelltra | Tarlatamab | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | 761344 | AMGEN INC | 09/15/2026 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/761344s002lbl.pdf#page=36 |
| Imfinzi | Durvalumab | INJECTABLE;INJECTION | 761069 | ASTRAZENECA UK LTD | 05/28/2026 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/761069s053lbl.pdf#page=88 |
| Imipramine Hydrochloride | Imipramine Hydrochloride | TABLET;ORAL | 087846 | SPECGX LLC | 06/29/2017 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/087846s028,087844s027,087845s027lbl.pdf#page=3 |
| Imjudo | Tremelimumab-Actl | INJECTABLE;INTRAVENOUS, SUBCUTANEOUS | 761270 | ASTRAZENECA | 11/10/2022 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761270s000lbl.pdf#page=32 |
| Imjudo | Tremelimumab-Actl | INJECTABLE;INTRAVENOUS | 761289 | ASTRAZENECA | 01/25/2024 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761289s002lbl.pdf#page=31 |
| Immgolis and Immgolis Intri | Golimumab | INJECTION, SOLUTION | 761452 | ACCORD BIOPHARMA INC. | 05/19/2026 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/761452Orig1s000lbl.pdf#page=63 |
| Imuldosa | Ustekinumab | INJECTION, SOLUTION, CONCENTRATE | 761364 | ACCORD BIOPHARMA INC | 11/20/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/761364s003lbl.pdf#page=26 |
| Incivek | Telaprevir | TABLET;ORAL | 201917 | VERTEX PHARMS | 03/25/2014 | http://www.fda.gov/downloads/Drugs/DrugSafety/UCM256383.pdf |
| Indocin | Indomethacin | SUPPOSITORY;RECTAL | 017814 | EGALET | 11/21/2024 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/017814s045lbl.pdf |
| Indocin | Indomethacin | SUSPENSION;ORAL | 018332 | EGALET | 11/21/2024 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/018332s043lbl.pdf |
| Indocin | Indomethacin | CAPSULE;ORAL | 016059 | EGALET | 11/21/2024 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/016059s102lbl.pdf#page=25 |
| Indocin SR | Indomethacin | CAPSULE, EXTENDED RELEASE;ORAL | 018185 | EGALET | 11/21/2024 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/018185s059lbl.pdf#page=26 |
| Indomethacin | Indomethacin | CAPSULE;ORAL | 018829 | CHARTWELL MOLECULES | 11/21/2024 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/018829s025lbl.pdf#page=18 |
| Indomethacin | Indomethacin | CAPSULE;ORAL | 018851 | HERITAGE | 11/21/2024 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/018851s028lbl.pdf#page=23 |
| Indomethacin | Indomethacin | CAPSULE;ORAL | 018858 | RISING | 11/21/2024 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/018858s049lbl.pdf |
| Inflectra | Infliximab-Dyyb | INJECTABLE;INJECTION | 125544 | CELLTRION INC | 09/03/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/125544s055lbl.pdf#page=61 |
| Ingrezza | Valbenazine | CAPSULE;ORAL | 209241 | NEUROCRINE BIOSCIENCES INC | 02/05/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/209241s029lbl.pdf#page=27 |
| Inpefa | Sotagliflozin | TABLET; ORAL | 216203 | LEXICON PHARMACEUTICALS | 08/11/2026 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/216203s003lbl.pdf#page=24 |
| Inrebic | Fedratinib Hydrochloride | CAPSULE;ORAL | 212327 | IMPACT | 03/18/2026 | http://www.accessdata.fda.gov/drugsatfda_docs/label/2026/212327s009lbl.pdf#page=24 |
| Intermezzo | Zolpidem Tartrate | TABLET;SUBLINGUAL | 022328 | PURDUE PHARMA | 08/18/2019 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022328s008lbl.pdf#page=20 |
| Intron A | Interferon Alfa-2b | VIAL | 103132 | SCHERING | 11/26/2021 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/103132s5196lbl.pdf#page=40 |
| Invirase | Saquinavir Mesylate | CAPSULE;ORAL | 020628 | HOFFMANN LA ROCHE | 03/28/2019 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020628s047,021785s023lbl.pdf#page=24 |
| Invirase | Saquinavir Mesylate | TABLET;ORAL | 021785 | HOFFMANN-LA ROCHE | 09/18/2020 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021785s025lbl.pdf#page=25 |
| Invokamet | Canagliflozin; METformin Hydrochloride | TABLET;ORAL | 204353 | JANSSEN PHARMS | 08/18/2026 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/204353s038s049lbl.pdf#page=60 |
| Invokamet XR | Canagliflozin; METformin Hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 205879 | JANSSEN PHARMS | 08/18/2026 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/205879s25s26lbl.pdf#page=60 |
| Invokana | Canagliflozin | TABLET;ORAL | 204042 | JANSSEN PHARMS | 08/23/2024 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/204042s041s042lbl.pdf#page=48 |
| Ixifi | Infliximab-Qbtx | INJECTABLE;INJECTION | 761072 | PFIZER INC | 10/09/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/761072s014lbl.pdf#page=46 |
| Jadenu | Deferasirox | TABLET;ORAL | 206910 | NOVARTIS PHARMS CORP | 07/23/2020 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/206910s015lbl.pdf#page=31 |
| Jadenu Sprinkle | Deferasirox | GRANULE;ORAL | 207968 | NOVARTIS | 07/23/2020 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/207968s009lbl.pdf#page=31 |
| Janumet | Metformin Hydrochloride; Sitagliptin Phosphate | TABLET;ORAL | 022044 | MERCK SHARP DOHME | 08/18/2026 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/022044s058lbl.pdf#page=33 |
| Janumet XR | Metformin Hydrochloride; Sitagliptin Phosphate | TABLET, EXTENDED RELEASE;ORAL | 202270 | MERCK SHARP DOHME | 06/21/2022 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/202270s026lbl.pdf#page=34 |
| Januvia | Sitagliptin Phosphate | TABLET;ORAL | 021995 | MERCK SHARP DOHME | 06/21/2022 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021995s050lbl.pdf#page=27 |
| Jardiance | Empagliflozin | TABLET;ORAL | 204629 | BOEHRINGER INGELHEIM | 10/24/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/204629s063lbl.pdf#page=47 |
| Jatenzo (Testosterone Undecanoate) | Testosterone Undecanoate | CAPSULE, SOFT GELATIN | 206089 | TOLMAR, INC | 09/12/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/206089s007lbl.pdf#page=19 |
| Jemperli | Dostarlimab-Gxly | INJECTABLE;INJECTION | 761174 | GLAXOSMITHKLINE | 10/20/2026 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/761174s015lbl.pdf#page=36 |
| Jemperli | Dostarlimab-Gxly | INJECTABLE;INJECTION | 761223 | GLAXOSMITHKLINE LLC | 08/17/2021 | http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/761223s000lbl.pdf#page=25 |
| Jentadueto | Linagliptin; METformin Hydrochloride | TABLET;ORAL | 201281 | BOEHRINGER INGELHEIM | 08/18/2026 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/201281s043lbl.pdf#page=21 |
| Jentadueto XR | Linagliptin; METformin Hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 208026 | BOEHRINGER INGELHEIM | 08/18/2026 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/208026s034lbl.pdf#page=22 |
| Jesduvroq | Daprodustat | TABLET;ORAL | 216951 | GLAXOSMITHKLINE | 02/01/2023 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/216951s000lbl.pdf#page=23 |
| Jeuveau | Prabotulinumtoxina-Xvfs | INJECTABLE;INJECTION | 761085 | EVOLUS INC | 07/12/2019 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761085s000lbl.pdf#page=9 |
| Jornay PM | Methylphenidate Hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 209311 | IRONSHORE PHARMS | 09/23/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/209311s013lbl.pdf#page=20 |
| Jubbonti | Denosumab | INJECTION | 761362 | SANDOZ INC | 10/29/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/761362s005lbl.pdf#page=29 |
| Juvisync | Simvastatin; Sitagliptin Phosphate | TABLET;ORAL | 202343 | MERCK SHARP DOHME | 02/24/2014 | http://www.fda.gov/downloads/Drugs/DrugSafety/UCM275945.pdf |
| Juxtapid | Lomitapide Mesylate | CAPSULE;ORAL | 203858 | AMRYT | 05/27/2021 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/203858s017lbl.pdf#page=32 |
| Jynarque | Tolvaptan | TABLET;ORAL | 204441 | OTSUKA | 09/16/2026 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/204441s016lbl.pdf#page=18 |
| Kadian | Morphine Sulfate | CAPSULE, EXTENDED RELEASE;ORAL | 020616 | ALLERGAN | 03/04/2021 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020616s065lbl.pdf#page=36 |
| Kalbitor | Ecallantide | INJECTABLE; INJECTION | 125277 | DYAX CORP. | 12/28/2020 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/125277s081lbl.pdf#page=13 |
| Kaletra | Lopinavir; Ritonavir | TABLET;ORAL | 021906 | ABBVIE | 10/21/2020 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021251s059,021906s054lbl.pdf#page=53 |
| Kaletra | Lopinavir; Ritonavir | CAPSULE;ORAL | 021226 | ABBVIE | 10/21/2020 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021226s049lbl.pdf#page=53 |
| Kaletra | Lopinavir; Ritonavir | SOLUTION;ORAL | 021251 | ABBVIE | 10/21/2020 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021251s059,021906s054lbl.pdf#page=53 |
| Kazano | Alogliptin Benzoate; METformin Hydrochloride | TABLET;ORAL | 203414 | TAKEDA PHARMS USA | 07/27/2023 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/203414s016lbl.pdf#page=32 |
| Keppra | Levetiracetam | TABLET;ORAL | 021035 | UCB INC | 03/12/2024 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021035s113,021505s052lbl.pdf#page=32 |
| Keppra | Levetiracetam | SOLUTION;ORAL | 021505 | UCB INC | 03/12/2024 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021035s113,021505s052lbl.pdf#page=32 |
| Keppra XR | Levetiracetam | TABLET, EXTENDED RELEASE;ORAL | 022285 | UCB INC | 03/12/2024 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022285s034lbl.pdf#page=26 |
| Kesimpta | Ofatumumab | SOLUTION;SUBCUTANEOUS | 125326 | NOVARTIS | 08/18/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/125326s083lbl.pdf#page=14 |
| Ketek | Telithromycin | TABLET;ORAL | 021144 | SANOFI AVENTIS US | 11/04/2015 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/021144s019lbl.pdf#page=29 |
| Kevzara | Sarilumab | INJECTABLE;INJECTION | 761037 | SANOFI SYNTHELABO | 06/10/2024 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761037s013lbl.pdf#page=31 |
| Keytruda | Pembrolizumab | SOLUTION;INTRAVENOUS | 125514 | MERCK SHARP DOHME | 10/27/2026 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/125514s191lblCorrected.pdf#page=197 |
| Keytruda Qlex | Pembrolizumab, Berahyaluronidase Alfa | INJECTABLE;SOLUTION | 761467 | MERCK SHARP & DOHME LLC | 07/15/2026 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/761467s012lbl.pdf#page=208 |
| Khedezla | Desvenlafaxine | TABLET, EXTENDED RELEASE;ORAL | 204683 | OSMOTICA PHARM CORP | 09/20/2021 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/204683s007lbl.pdf#page=24 |
| Khindivi | Hydrocortisone | SOLUTION;ORAL | 218980 | ETON PHARMACEUTICALS INC | 05/28/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/218980s000lbl.pdf#page=16 |
| Kisunla (Donanemab-Azbt) | Donanemab | INJECTION, SOLUTION | 761248 | ELI LILLY AND CO | 07/01/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/761248s004lbl.pdf#page=18 |
| Klonopin | Clonazepam | TABLET;ORAL | 017533 | CHEPLAPHARM | 01/13/2023 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/017533s062lbl.pdf#page=24 |
| Kombiglyze XR | Metformin Hydrochloride; Saxagliptin Hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 200678 | ASTRAZENECA AB | 08/18/2026 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/200678s030lbl.pdf#page=47 |
| Konvomep | Omeprazole; Sodium Bicarbonate | SUSPENSION;ORAL | 213593 | AZURITY | 08/30/2022 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/213593s000lbl.pdf#page=28 |
| Korlym | Mifepristone | TABLET;ORAL | 202107 | CORCEPT THERAP | 11/05/2019 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/202107s008lbl.pdf#page=20 |
| Krystexxa | Pegloticase | INJECTABLE; INJECTION | 125293 | HORIZON PHARMA | 07/07/2022 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/125293s104lbl.pdf#page=18 |
| Kynamro | Mipomersen Sodium | SOLUTION;SUBCUTANEOUS | 203568 | KASTLE THERAPS LLC | 03/18/2019 | http://www.fda.gov/downloads/Drugs/DrugSafety/UCM337730.pdf |
| Kyzatrex (Testosterone Undecanoate) | Testosterone Undecanoate | CAPSULE, GELATIN COATED | 213953 | MARIUS PHARMACEUTICALS, LLC | 07/11/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/213953s005lbl.pdf#page=21 |
| Lacosamide | Lacosamide | SOLUTION;ORAL | 204839 | AMNEAL PHARMS | 10/27/2017 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/LacosamideTabletsCVMedGuide.pdf |
| Lacosamide | Lacosamide | TABLET;ORAL | 204855 | ACTAVIS LABS FL INC | 10/27/2017 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/LACOSAMIDE TABLETSMedGuide.pdf |
| Lacosamide | Lacosamide | TABLET;ORAL | 204857 | AMNEAL PHARMS NY | 08/10/2021 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/LACOSAMIDE ORAL SOLUTIONMed Guide.pdf |
| Lamictal | Lamotrigine | TABLET;ORAL | 020241 | GLAXOSMITHKLINE LLC | 03/31/2021 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020241s064,020764s057,022251s028lbl.pdf#page=65 |
| Lamictal CD | Lamotrigine | TABLET, FOR SUSPENSION;ORAL | 020764 | GLAXOSMITHKLINE LLC | 03/31/2021 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020241s064,020764s057,022251s028lbl.pdf#page=65 |
| Lamictal ODT | Lamotrigine | TABLET, ORALLY DISINTEGRATING;ORAL | 022251 | GLAXOSMITHKLINE LLC | 10/10/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/020241s068s069,020764s061s062,022251s032s033lbl.pdf#page=123 |
| Lamictal XR | Lamotrigine | TABLET, EXTENDED RELEASE;ORAL | 022115 | GLAXOSMITHKLINE LLC | 10/10/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/022115s033s034lbl.pdf#page=52 |
| Lamictal XR | Lamotrigine | TABLET, EXTENDED RELEASE; ORAL | 022509 | SMITHKLINE BEECHAM | 01/29/2010 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/022509lbl.pdf#page=39 |
| Lamisil | Terbinafine Hydrochloride | TABLET;ORAL | 020539 | NOVARTIS | 03/29/2019 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020539s033lbl.pdf#page=11 |
| Lamisil | Terbinafine Hydrochloride | GRANULE;ORAL | 022071 | NOVARTIS | 03/29/2019 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020539s029,022071s013lbl.pdf#page=10 |
| Lamivudine, Nevirapine and Zidovudine | Lamivudine; Nevirapine; Zidovudine | TABLET;ORAL | 205626 | MICRO LABS | 08/13/2018 | http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/205626s000lbl.pdf#page=50 |
| Lariam | Mefloquine Hydrochloride | TABLET;ORAL | 019591 | ROCHE | 04/29/2011 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/019591s026s028lbl.pdf#page=13 |
| Latuda | Lurasidone Hydrochloride | TABLET;ORAL | 200603 | SUNOVION PHARMS INC | 01/22/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/200603s041lbl.pdf#page=63 |
| Lazanda | Fentanyl Citrate | SPRAY, METERED;NASAL | 022569 | BTCP PHARMA | 12/03/2021 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022569s030lbl.pdf#page=35 |
| Lemtrada | Alemtuzumab | INJECTABLE;INJECTION | 103948 | GENZYME | 05/20/2024 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/103948s5185lbl.pdf#page=30 |
| Leqembi | Ecanemab-Irmb | INJECTABLE;INTRAVENOUS | 761269 | EISAI INC | 08/21/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/761269s013lbl.pdf#page=22 |
| Leqembi | Lecanemab-Irmb | INJECTABLE;SOLUTION | 761375 | EISAI INC | 07/15/2026 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/761375s001lbl.pdf#page=28 |
| Letairis | Ambrisentan | TABLET;ORAL | 022081 | GILEAD | 06/08/2021 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022081s041lbl.pdf#page=26 |
| Levaquin | Levofloxacin | SOLUTION;ORAL | 021721 | JANSSEN PHARMS | 02/08/2017 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020634s068,020635s074,021721s035lbl.pdf#page=59 |
| Levaquin | Levofloxacin | TABLET;ORAL | 020634 | JANSSEN PHARMS | 02/08/2017 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020634s073lbl.pdf#page=54 |
| Levaquin | Levofloxacin | INJECTABLE;INJECTION | 020635 | JANSSEN PHARMS | 02/08/2017 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020634s068,020635s074,021721s035lbl.pdf#page=59 |
| Levaquin | Levofloxacin | INJECTABLE;INJECTION | 020635 | JANSSEN PHARMS | 02/08/2017 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020634s068,020635s074,021721s035lbl.pdf#page=59 |
| Lexapro | Escitalopram Oxalate | TABLET;ORAL | 021323 | ALLERGAN | 04/19/2024 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021323s057,021365s040lbl.pdf#page=30 |
| Lexapro | Escitalopram Oxalate | SOLUTION;ORAL | 021365 | ALLERGAN | 04/19/2024 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021323s057,021365s040lbl.pdf#page=30 |
| Librax | Chlordiazepoxide Hydrochloride; Clidinium Bromide | CAPSULE;ORAL | 012750 | BAUSCH | 01/13/2023 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/012750s068lbl.pdf#page=13 |
| Librium | Chlordiazepoxide Hydrochloride | CAPSULE;ORAL | 012249 | VALEANT PHARM INTL | 12/16/2016 | http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/012249s049lbl.pdf#page=8 |
| Libtayo | Cemiplimab-Rwlc | INJECTABLE;INTRAVENOUS | 761097 | REGENERON PHARMACEUTICALS | 10/08/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/761097s030lbl.pdf#page=40 |
| Licart | Diclofenac Epolamine | SYSTEM;TOPICAL | 206976 | IBSA INST BIO | 11/21/2024 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/206976s016lbl.pdf#page=21 |
| Limbitrol | Amitriptyline Hydrochloride; Chlordiazepoxide | TABLET;ORAL | 016949 | HERITAGE PHARMS INC | 06/24/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/016949s044lbl.pdf#page=16 |
| Limbitrol DS | Amitriptyline Hydrochloride; Chlordiazepoxide | TABLET;ORAL | 016949 | HERITAGE PHARMS INC | 06/24/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/016949s044lbl.pdf#page=16 |
| Lindane | Lindane | SHAMPOO;TOPICAL | 087266 | OLTA PHARMS | 04/05/2004 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/LindaneLotionMedGuide.pdf |
| Lindane | Lindane | LOTION;TOPICAL | 087313 | OLTA PHARMS | 09/04/2001 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/LindaneShampooMedGuide.pdf |
| Linzess | Linaclotide | CAPSULE;ORAL | 202811 | ALLERGAN | 11/04/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/202811s022lbl.pdf#page=26 |
| Lithium Carbonate | Lithium Carbonate | CAPSULE;ORAL | 017812 | HIKMA | 10/13/2022 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/017812s036,018421s035,018558s030lbl.pdf#page=19 |
| Lithium Carbonate | Lithium Carbonate | TABLET;ORAL | 018558 | HIKMA | 10/13/2022 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/017812s036,018421s035,018558s030lbl.pdf#page=19 |
| Lithium Citrate | Lithium Citrate | SYRUP;ORAL | 018421 | HIKMA | 10/13/2022 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/017812s036,018421s035,018558s030lbl.pdf#page=19 |
| Loqtorzi | Toripalimab-Tpzi | INJECTABLE;INTRAVENOUS | 761240 | COHERUS BIOSCIENCES INC | 04/22/2024 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761240s000lbl.pdf#page=24 |
| Loreev XR | Lorazepam | CAPSULE, EXTENDED RELEASE;ORAL | 214826 | Almatica Pharma | 01/13/2023 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/214826s003lbl.pdf#page=16 |
| Lotronex | Alosetron Hydrochloride | TABLET;ORAL | 021107 | SEBELA IRELAND LTD | 04/03/2019 | http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088624.pdf |
| Lumoxiti | Moxetumomab Pasudotox-Tdfk | INJECTABLE;INJECTION | 761104 | INNATE PHARMA | 08/20/2020 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/761104s003lbl.pdf#page=18 |
| Lunesta | Eszopiclone | TABLET;ORAL | 021476 | SUNOVION PHARMS INC | 08/18/2019 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021476Orig1s038rplLBL.pdf#page=26 |
| Lunsumio | Mosunetuzumab-Axgb | INJECTABLE;INTRAVENOUS | 761263 | GENENTECH, INC | 12/19/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/761263s006lbl.pdf#page=42 |
| Lupaneta Pack | Leuprolide Acetate for Depot Suspension, Norethindrone Acetate Usp | INJECTABLE;INTRAMUSCULAR; TABLET;ORAL | 203696 | GLENMARK PHARMACEUTICALS | 08/09/2023 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/203696s005s006lbl.pdf#page=30 |
| Lupkynis | Voclosporin | CAPSULE;ORAL | 213716 | AURINIA | 10/08/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/213716s008lbl.pdf#page=25 |
| Lupron | Leuprolide Acetate | INJECTABLE;INJECTION | 019010 | ABBVIE ENDOCRINE INC | 12/10/2018 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/019010s038lbl.pdf#page=27 |
| Lupron Depot-Ped Kit | Leuprolide Acetate | POWDER;INTRAMUSCULAR | 020263 | ABBVIE ENDOCRINE INC | 11/14/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/020263s057lbl.pdf#page=26 |
| Luvox | Fluvoxamine Maleate | TABLET;ORAL | 021519 | ANI PHARMS | 08/18/2023 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021519s026lbl.pdf#page=32 |
| Luvox CR | Fluvoxamine Maleate | CAPSULE, EXTENDED RELEASE;ORAL | 022033 | JAZZ PHARMS | 01/04/2017 | http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/022033s011lbl.pdf#page=26 |
| Lybalvi | Olanzapine; Samidorphan L-Malate | TABLET;ORAL | 213378 | ALKERMES INC | 02/28/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/213378s008lbl.pdf#page=41 |
| Lynozyfic (Linvoseltamab) | Linvoseltamab | INJECTION, SOLUTION | 761400 | REGENERON PHARMACEUTICALS, INC. | 07/02/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/761400s000lbl.pdf#page=30 |
| Lynparza | Olaparib | CAPSULE;ORAL | 206162 | ASTRAZENECA | 09/27/2018 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/206162s011lbl.pdf#page=16 |
| Lynparza | Olaparib | TABLET;ORAL | 208558 | ASTRAZENECA | 07/10/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/208558s031lbl.pdf#page=58 |
| Lyrica | Pregabalin | CAPSULE;ORAL | 021446 | UPJOHN | 12/15/2023 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021446s041,022488s018lbl.pdf#page=57 |
| Lyrica | Pregabalin | SOLUTION;ORAL | 022488 | UPJOHN | 12/13/2023 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021446s041,022488s018lbl.pdf#page=57 |
| Lyrica CR | Pregabalin | TABLET, EXTENDED RELEASE;ORAL | 209501 | UPJOHN | 12/13/2023 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/209501s005lbl.pdf#page=31 |
| Magnevist | Gadopentetate Dimeglumine | INJECTABLE;INJECTION | 019596 | BAYER HLTHCARE | 07/25/2018 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/019596s064s065lbl.pdf#page=12 |
| Magnevist | Gadopentetate Dimeglumine | INJECTABLE;INJECTION | 021037 | BAYER HLTHCARE | 07/25/2018 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021037s037s038lbl.pdf#page=13 |
| Marplan | Isocarboxazid | TABLET;ORAL | 011961 | VALIDUS PHARMS INC | 11/08/2018 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/011961s045lbl.pdf#page=16 |
| Mavenclad | Cladribine | TABLET;ORAL | 022561 | EMD SERONO INC | 05/18/2026 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/022561s013lbl.pdf#page=28 |
| Mayzent | Siponimod Fumaric Acid | TABLET;ORAL | 209884 | NOVARTIS | 07/10/2026 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/209884s021lbl.pdf#page=24 |
| Mektov | Binimetinib | TABLET;ORAL | 210498 | ARRAY BIOPHARMA INC | 09/12/2024 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/210498s010lbl.pdf#page=21 |
| Meridia | Sibutramine Hydrochloride | CAPSULE;ORAL | 020632 | ABBOTT | 08/04/2010 | http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/020632s034s035MedGuide.pdf |
| Metadate CD | Methylphenidate Hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 021259 | LANNETT CO INC | 09/23/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/021259s036lbl.pdf#page=16 |
| Methylin | Methylphenidate Hydrochloride | SOLUTION;ORAL | 021419 | SPECGX LLC | 10/13/2023 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021419s023lbl.pdf#page=17 |
| Methylin | Methylphenidate Hydrochloride | TABLET, CHEWABLE;ORAL | 021475 | SPECGX LLC | 01/08/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/021475s013lbl.pdf#page=20 |
| Metoclopramide Hydrochloride | Metoclopramide Hydrochloride | SOLUTION;ORAL | 074703 | WOCKHARDT BIO AG | 04/08/2014 | http://www.fda.gov/downloads/Drugs/DrugSafety/UCM244086.pdf |
| Metozolv ODT | Metoclopramide Hydrochloride | TABLET, ORALLY DISINTEGRATING;ORAL | 022246 | SALIX PHARMS | 02/28/2019 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022246s009lbl.pdf#page=18 |
| Mifeprex | Mifepristone | TABLET; ORAL | 020687 | DANCO LABS LLC | 03/23/2023 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/020687Orig1s026lbl.pdf#page=16 |
| Mircera | Methoxy Polyethylene Glycol-Epoetin Beta | SOLUTION; INJECTION | 125164 | HOFFMAN-LA ROCHE | 06/04/2024 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/125164s087lblcorretion.pdf#page=23 |
| Mircera | Methoxy Polyethylene Glycol-Epoetin Beta | INJECTABLE; SUBCUTANEOUS | 126164 | Vifor International Inc | 04/13/2023 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/126164s087lbl.pdf#page=27 |
| Mitigare | Colchicine | CAPSULE;ORAL | 204820 | HIKMA AMERICAS | 09/26/2014 | http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/204820s000lbl.pdf#page=11 |
| Mitigare | Colchicine | CAPSULE;ORAL | 204820 | HIKMA INTL PHARMS | 09/26/2014 | http://www.fda.gov/downloads/Drugs/DrugSafety/UCM417495.pdf |
| Mobic | Meloxicam | TABLET;ORAL | 020938 | BOEHRINGER INGELHEIM | 11/21/2024 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/020938s030lbl.pdf#page=16 |
| Mobic | Meloxicam | SUSPENSION;ORAL | 021530 | AVONDALE PHARMS | 11/21/2024 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/021530s020lbl.pdf#page=16 |
| Morphabond ER | Morphine Sulfate | TABLET, EXTENDED RELEASE;ORAL | 206544 | DAIICHI SANKYO INC | 10/07/2019 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/206544s012lbl.pdf#page=38 |
| Morphine Sulfate | Morphine Sulfate | SOLUTION;ORAL | 201517 | LANNETT CO INC | 12/15/2023 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/201517s018lbl.pdf#page=30 |
| Morphine Sulfate | Morphine Sulfate | SOLUTION;ORAL | 022195 | HIKMA | 12/15/2023 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022195s021lbl.pdf#page=23 |
| Morphine Sulfate | Morphine Sulfate | TABLET;ORAL | 022207 | HIKMA | 12/15/2023 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022207s011lbl.pdf#page=29 |
| Motpoly XR | Lacosamide | CAPSULE, EXTENDED RELEASE;ORAL | 216185 | Aucta Pharmaceuticals | 06/07/2024 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/216185s000lbl.pdf#page=22 |
| Motrin | Ibuprofen | TABLET;ORAL | 017463 | MCNEIL CONSUMER | 09/10/2007 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/017463s104lbl.pdf#page=13 |
| Mounjaro | Tirzepatide | INJECTABLE; SUBCUTANEOUS | 215866 | ELI LILLY AND COMPANY | 09/01/2026 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/215866s044s045lbl.pdf#page=27 |
| Movantik | Naloxegol Oxalate | TABLET;ORAL | 204760 | REDHILL | 04/13/2020 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/204760s009lbl.pdf#page=16 |
| Moviprep | Ascorbic Acid; Polyethylene Glycol 3350; Potassium Chloride; Sodium Ascorbate; Sodium Chloride; Sodium Sulfate | FOR SOLUTION;ORAL | 021881 | SALIX PHARMS | 05/14/2021 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021881s023lbl.pdf#page=13 |
| Moxifloxacin Hydrochloride | Moxifloxacin Hydrochloride | SOLUTION;INTRAVENOUS | 205572 | FRESENIUS KABI USA | 07/26/2016 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/205572s007lbl.pdf#page=49 |
| MS Contin | Morphine Sulfate | TABLET, EXTENDED RELEASE;ORAL | 019516 | PURDUE PHARMA LP | 12/22/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/019516s062lbl.pdf#page=35 |
| Multaq | Dronedarone Hydrochloride | TABLET;ORAL | 022425 | SANOFI AVENTIS US | 10/23/2023 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022425s028s030lbl.pdf#page=24 |
| Multihance | Gadobenate Dimeglumine | INJECTABLE;INTRAVENOUS | 021357 | BRACCO | 03/05/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/021357s028lbl.pdf#page=17 |
| Multihance Multipack | Gadobenate Dimeglumine | INJECTABLE;INTRAVENOUS | 021358 | BRACCO | 03/05/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/021358s026lbl.pdf#page=18 |
| Myalept | Metreleptin | INJECTABLE;INJECTION | 125390 | AEGERION | 02/28/2022 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/125390s024lbl.pdf#page=16 |
| Mydayis | Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate | CAPSULE, EXTENDED RELEASE;ORAL | 022063 | TAKEDA PHARMS USA | 10/13/2023 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022063s005lbl.pdf#page=25 |
| Myfortic | Mycophenolic Sodium | TABLET, DELAYED RELEASE;ORAL | 050791 | NOVARTIS | 08/04/2026 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/050791s042s043lbl.pdf#page=23 |
| Myobloc | Botulinum Toxin Type B | VIAL | 103846 | ELAN PHARM | 03/10/2021 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/103846s5195lbl.pdf#page=17 |
| Mysoline | Primidone | TABLET;ORAL | 009170 | VALEANT | 06/10/2020 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/009170Orig1s040lbl.pdf#page=7 |
| Nalfon | Fenoprofen Calcium | CAPSULE;ORAL | 017604 | XSPIRE PHARMA | 11/21/2024 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/017604s054lbl.pdf#page=16 |
| Naprelan | Naproxen Sodium | TABLET, EXTENDED RELEASE;ORAL | 020353 | ALMATICA | 11/21/2024 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/020353s041lbl.pdf#page=21 |
| Naprosyn | Naproxen | SUSPENSION;ORAL | 018965 | ATNAHS PHARMA US | 11/21/2024 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/018965s028lbl.pdf#page=22 |
| Naprosyn | Naproxen | TABLET;ORAL | 017581 | ATNAHS PHARMA US | 11/21/2024 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/017581s117,018164s067,020067s026lbl.pdf |
| Nardil | Phenelzine Sulfate | TABLET;ORAL | 011909 | PARKE DAVIS | 08/02/2007 | http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088660.pdf |
| Natalizumab | Natalizumab | INJECTION | 761322 | SANDOZ INC | 10/30/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/761322s002lbl.pdf#page=26 |
| Natpara | Parathyroid Hormone | INJECTABLE;INJECTION | 125511 | NPS PHARMS INC | 07/01/2020 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/125511s016lbl.pdf#page=18 |
| Nayzilam | Midazolam | SPRAY;NASAL | 211321 | UCB INC | 01/13/2023 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/211321s008lbl.pdf#page=26 |
| Nesina | Alogliptin Benzoate | TABLET;ORAL | 022271 | TAKEDA PHARMS USA | 07/27/2023 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022271s015lbl.pdf#page=28 |
| Neurontin | Gabapentin | SOLUTION;ORAL | 021129 | UPJOHN | 12/16/2020 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020235s069,020882s050,021129s050lbl.pdf#Page=28 |
| Neurontin | Gabapentin | TABLET;ORAL | 020882 | UPJOHN | 12/16/2020 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020235s069,020882s050,021129s050lbl.pdf#Page=28 |
| Neurontin | Gabapentin | CAPSULE;ORAL | 020235 | UPJOHN | 12/16/2020 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020235s069,020882s050,021129s050lbl.pdf#Page=28 |
| Nexium | Esomeprazole Magnesium | FOR SUSPENSION, DELAYED RELEASE;ORAL | 022101 | ASTRAZENECA | 07/18/2023 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021153s060,021957s027,022101s024lbl.pdf#page=40 |
| Nexium | Esomeprazole Magnesium | CAPSULE, DELAYED REL PELLETS;ORAL | 021153 | ASTRAZENECA | 07/18/2023 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021153s060,021957s027,022101s024lbl.pdf#page=40 |
| Nexium | Esomeprazole Magnesium | FOR SUSPENSION, DELAYED RELEASE;ORAL | 021957 | ASTRAZENECA | 07/18/2023 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021153s060,021957s027,022101s024lbl.pdf#page=40 |
| Nilotinib | Nilotinib D-Tartrate | CAPSULE;ORAL | 218922 | CIPLA USA, INC | 07/10/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/218922s001lbl.pdf#page=38 |
| Nizoral | Ketoconazole | TABLET;ORAL | 018533 | JANSSEN PHARMS | 07/30/2013 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/018533s040lbl.pdf#page=19 |
| Nocdurna | Desmopressin Acetate | TABLET;SUBLINGUAL | 022517 | FERRING PHARMS INC | 06/21/2018 | http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/022517s000lbl.pdf#page=14 |
| Noctiva | Desmopressin Acetate | SPRAY, METERED;NASAL | 201656 | SERENITY PHARMS LLC | 03/03/2017 | http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/201656lbl.pdf#page=13 |
| Nolvadex | Tamoxifen Citrate | TABLET;ORAL | 017970 | ASTRAZENECA | 03/13/2009 | http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088661.pdf |
| Norco | Acetaminophen; Hydrocodone Bitartrate | TABLET;ORAL | 040099 | APIL | 03/04/2021 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/040099s023lbl.pdf#page=23 |
| Noroxin | Norfloxacin | TABLET;ORAL | 019384 | MERCK | 07/26/2016 | http://www.fda.gov/downloads/Drugs/DrugSafety/UCM246795.pdf |
| Norpramin | Desipramine Hydrochloride | TABLET;ORAL | 014399 | VALIDUS PHARMS | 06/24/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/%014399s072lbl.pdf#page=16 |
| Novantrone | Mitoxantrone Hydrochloride | INJECTABLE;INJECTION | 019297 | EMD SERONO | 03/23/2012 | http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/019297s035mg.pdf |
| Nplate | Romiplostim | INJECTABLE; SUBCUTANEOUS | 125268 | AMGEN | 02/21/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/125268s176lbl.pdf#page=19 |
| Nucynta | Tapentadol Hydrochloride | TABLET;ORAL | 022304 | COLLEGIUM PHARM INC | 06/14/2024 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022304s026lbl.pdf#page=40 |
| Nucynta | Tapentadol Hydrochloride | SOLUTION;ORAL | 203794 | COLLEGIUM PHARM INC | 06/14/2024 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/203794s011lbl.pdf#page=37 |
| Nucynta ER | Tapentadol Hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 200533 | COLLEGIUM PHARM INC | 06/14/2024 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/200533s027lbl.pdf#page=40 |
| Nulojix | Belatacept | INJECTABLE; INJECTION | 125288 | BRISTOL MYERS SQUIBB | 07/28/2021 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/125288s075lbl.pdf#page=49 |
| Nulytely | Polyethylene Glycol 3350; Potassium Chloride; Sodium Bicarbonate; Sodium Chloride | FOR SOLUTION;ORAL | 019797 | BRAINTREE | 05/14/2021 | http://www.fda.gov/downloads/Drugs/DrugSafety/UCM370636.pdf |
| Nulytely-Flavored | Polyethylene Glycol 3350; Potassium Chloride; Sodium Bicarbonate; Sodium Chloride | FOR SOLUTION;ORAL | 019797 | BRAINTREE | 05/14/2021 | http://www.fda.gov/downloads/Drugs/DrugSafety/UCM370636.pdf |
| Nuvigil | Armodafinil | TABLET;ORAL | 021875 | CEPHALON | 02/07/2017 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021875s023lbl.pdf#page=24 |
| Obredon | Guaifenesin; Hydrocodone Bitartrate | SOLUTION;ORAL | 205474 | SOVEREIGN PHARMS | 12/15/2023 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/205474s008lbl.pdf#page=23 |
| Ocaliva | Obeticholic Acid | TABLET;ORAL | 207999 | INTERCEPT PHARMS INC | 05/26/2021 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/207999s007lbl.pdf#page=22 |
| Ocrevus | Ocrelizumab | INJECTABLE;INJECTION | 761053 | GENENTECH INC | 05/19/2026 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/761053s038lbl.pdf#page=27 |
| Ocrevus Zunovo | Ocrelizumab and Hyaluronidazse-Ocsq | INJECTABLE;SUBCUTANEOUS | 761371 | GENETECH, INC. | 08/18/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/761371s001lbl.pdf#page=23 |
| Odomzo | Sonidegib Phosphate | CAPSULE;ORAL | 205266 | SUN PHARMA GLOBAL | 08/22/2023 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/205266s009lbl.pdf#page=14 |
| Oleptro | Trazodone Hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 022411 | ANGELINI PHARMA | 07/17/2014 | http://www.fda.gov/downloads/Drugs/DrugSafety/UCM202202.pdf |
| Olumiant | Baricitinib | TABLET;ORAL | 207924 | ELI LILLY AND CO | 10/21/2026 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/207924s010lbl.pdf#page=33 |
| Omalizumab-Igec | Omalizumab | INJECTION, SOLUTION | 761399 | CELLTRION, INC. | 12/01/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/761399s004lbl.pdf#page=85 |
| Omniscan | Gadodiamide | INJECTABLE;INJECTION | 022066 | GE HEALTHCARE | 03/05/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/020123s052,022066s015lbl.pdf#page=23 |
| Omniscan | Gadodiamide | INJECTABLE;INJECTION | 020123 | GE HEALTHCARE | 03/05/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/020123s052,022066s015lbl.pdf#page=23 |
| Omontys | Peginesatide Acetate | SOLUTION;INTRAVENOUS, SUBCUTANEOUS | 202799 | TAKEDA PHARMS USA | 12/04/2012 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/202799s001lbl.pdf#page=15 |
| Omvoh | Mirikizumab-Mrkz | INJECTABLE;INTRAVENOUS, SUBCUTANEOUS | 761279 | ELI LILLY AND COMPANY | 10/23/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/761279s005lbl.pdf#page=20 |
| Onfi | Clobazam | TABLET;ORAL | 202067 | LUNDBECK PHARMS LLC | 03/12/2024 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/202067s007,203993s009lbl.pdf#page=29 |
| Onfi | Clobazam | SUSPENSION;ORAL | 203993 | LUNDBECK PHARMS LLC | 03/12/2024 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/202067s007,203993s009lbl.pdf#page=29 |
| Onglyza | Saxagliptin Hydrochloride | TABLET;ORAL | 022350 | ASTRAZENECA AB | 07/01/2019 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022350s023lbl.pdf#page=31 |
| Onsolis | Fentanyl Citrate | FILM;BUCCAL | 022266 | BDSI | 12/03/2021 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022266s025lbl.pdf#page=32 |
| Opana | Oxymorphone Hydrochloride | TABLET;ORAL | 021611 | ENDO PHARMS | 10/25/2019 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021611s016lbl.pdf#page=27 |
| Opana ER | Oxymorphone Hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 021610 | ENDO PHARMS | 12/15/2023 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021610s031lbl.pdf#page=32 |
| Opana ER | Oxymorphone Hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 201655 | ENDO PHARMS | 10/07/2019 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/201655s026lbl.pdf#page=26 |
| Opdivo | Nivolumab | INJECTABLE;INJECTION | 125554 | BRISTOL MYERS SQUIBB | 08/18/2026 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/125554s138lbl.pdf#page=187 |
| Opdivo Qvantig | Nivolumab and Hyaluronidase-Nvhy | INJECTABLE;SUBCUTANEOUS | 761429 | BRISTOL-MYERS SQUIBB COMPANY | 12/27/2024 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/761429s000lbl.pdf#page=148 |
| Opdivo Qvantig | Nivolumab and Hyaluronidase-Nvhy | INJECTABLE;SUBCUTANEOUS | 761381 | BRISTOL-MYERS SQUIBB COMPANY | 11/24/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/761381s005lbl.pdf#page=165 |
| Opsumit | Macitentan | TABLET;ORAL | 204410 | ACTELION | 02/28/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/204410s029lbl.pdf#page=20 |
| Optimark | Gadoversetamide | INJECTABLE;INJECTION | 020937 | LIEBEL-FLARSHEIM | 11/02/2018 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020937s028,020975s029,020976s030lbl.pdf#page=14 |
| Optimark | Gadoversetamide | INJECTABLE;INJECTION | 020975 | LIEBEL-FLARSHEIM | 11/02/2018 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020975s028lbl.pdf#page=13 |
| Optimark in Plastic Container | Gadoversetamide | INJECTABLE;INJECTION | 020976 | LIEBEL-FLARSHEIM | 11/02/2018 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020976s029lbl.pdf#page=13 |
| Opzelura | Ruxolitinib Phosphate | CREAM;TOPICAL | 215309 | INCYTE CORP | 07/10/2026 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/215309s009sdn953lbl.pdf#page=23 |
| Oriahnn (Copackaged) | Elagolix Sodium,Estradiol,Norethindrone Acetate; Elagolix Sodium | CAPSULE;ORAL | 213388 | ABBVIE INC | 05/29/2023 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/213388s003lbl.pdf#page=29 |
| Orilissa | Elagolix Sodium | TABLET;ORAL | 210450 | ABBVIE INC | 06/05/2023 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/210450s009lbl.pdf#page=27 |
| Oseni | Alogliptin Benzoate; Pioglitazone Hydrochloride | TABLET;ORAL | 022426 | TAKEDA PHARMS USA | 06/28/2024 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022426s012lbl.pdf#page=43 |
| Osmoprep | Sodium Phosphate, Dibasic, Anhydrous; Sodium Phosphate, Monobasic, Monohydrate | TABLET;ORAL | 021892 | SALIX PHARMS | 11/29/2018 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021892s014lbl.pdf#page=13 |
| Ospomyv | Denosumab-Dssb | INJECTABLE;SUBCUTANEOUS | 761392 | SAMSUNG BIOPES CO., LTD | 10/29/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/761392s000lbl.pdf#page=32 |
| Otulfi | Ustekinumab-Aauz | INJECTABLE;INTRAVENOUS | 761379 | FRESENIUS KABI USA | 04/30/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/761379Orig2s000lbl.pdf#page=36 |
| Oxaydo | Oxycodone Hydrochloride | TABLET;ORAL | 202080 | ZYLA | 04/19/2024 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/202080s013lbl.pdf#page=30 |
| Oxtellar XR | Oxcarbazepine | TABLET, EXTENDED RELEASE;ORAL | 202810 | SUPERNUS PHARMS | 08/14/2024 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/202810s020lbl.pdf#page=24 |
| Oxycodone Hydrochloride | Oxycodone Hydrochloride | SOLUTION;ORAL | 200535 | GENUS LIFESCIENCES | 04/19/2024 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/200535s022lbl.pdf#page=35 |
| Oxycodone Hydrochloride | Oxycodone Hydrochloride | SOLUTION;ORAL | 201194 | VISTAPHARM | 04/19/2024 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/201194s017lbl.pdf#page=34 |
| Oxycodone Hydrochloride Capsules | Oxycodone Hydrochloride | CAPSULE;ORAL | 200534 | GENUS LIFESCIENCES | 04/19/2024 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/200534s013lbl.pdf#page=32 |
| Oxycontin | Oxycodone Hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 022272 | PURDUE PHARMA LP | 12/15/2023 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022272s048lbl.pdf#page=49 |
| Oxymorphone Hydrochloride | Oxymorphone Hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 079046 | ACTAVIS ELIZABETH | 03/04/2021 | http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/079046s000mg.pdf |
| Ozempic | Semaglutide | SOLUTION;SUBCUTANEOUS | 209637 | NOVO | 10/14/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/209637s035,209637s037lbl.pdf#page=31 |
| Pacerone | Amiodarone Hydrochloride | TABLET;ORAL | 075135 | UPSHER SMITH LABS | 11/01/2019 | http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088668.pdf |
| Palladone | Hydromorphone Hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 021044 | PURDUE PHARMA LP | 04/16/2014 | http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088670.pdf |
| Palynziq | Pegvaliase-Pqpz | INJECTABLE;INJECTION | 761079 | BIOMARIN PHARM | 11/20/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/761079s034lbl.pdf#page=25 |
| Pamelor | Nortriptyline Hydrochloride | SOLUTION;ORAL | 018012 | SPECGX LLC | 07/28/2014 | http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088671.pdf |
| Pamelor | Nortriptyline Hydrochloride | CAPSULE;ORAL | 018013 | SPECGX LLC | 04/09/2019 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/018013s064lbl.pdf#page=15 |
| Pancreaze | Pancrelipase (Amylase;Lipase;Protease) | CAPSULE, DELAYED RELEASE;ORAL | 022523 | VIVUS INC | 02/28/2024 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022523s013lbl.pdf#page=16 |
| Parnate | Tranylcypromine Sulfate | TABLET;ORAL | 012342 | CONCORDIA | 01/04/2018 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/012342s064lbl.pdf#page=18 |
| Paxil | Paroxetine Hydrochloride | SUSPENSION;ORAL | 020710 | APOTEX TECHNOLOGIES | 11/26/2024 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/020031s083,020710s051lbl.pdf#page=39 |
| Paxil | Paroxetine Hydrochloride | TABLET;ORAL | 020031 | APOTEX TECHNOLOGIES | 11/26/2024 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/020031s083,020710s051lbl.pdf#page=39 |
| Paxil CR | Paroxetine Hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 020936 | APOTEX TECHNOLOGIES | 02/23/2024 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/020936s057s064lbl.pdf#page=30 |
| Peganone | Ethotoin | TABLET;ORAL | 010841 | RECORDATI RARE | 02/27/2017 | http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/010841s022MedGuide.pdf |
| Pegasys | Peginterferon Alfa-2a | VIAL; SUBCUTANEOUS | 103964 | HOFFMAN-LA ROCHE | 12/11/2023 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/103964s5276lbl.pdf#page=37 |
| Pegasys | Peginterferon Alfa-2a | SYRINGE | 103964 | HOFFMAN-LA ROCHE | 12/11/2023 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/103964s5276lbl.pdf#page=37 |
| Pegintron | Peginterferon Alfa-2b | SYRINGE | 103949 | SCHERING | 12/21/2018 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/103949s5313lbl.pdf#page=29 |
| Pembrolizumab and Berahyaluronidase Alfa | Pembrolizumab, Berahyaluronidase Alfa | INJECTABLE;SOLUTION | 761495 | MERCK SHARP AND DOHME LLC | 10/15/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/761495s000lbl.pdf#page=182 |
| Pennsaid | Diclofenac Sodium | SOLUTION;TOPICAL | 020947 | NUVO PHARMS INC | 05/09/2016 | http://www.fda.gov/downloads/Drugs/DrugSafety/UCM191085.pdf |
| Pennsaid | Diclofenac Sodium | SOLUTION;TOPICAL | 204623 | HORIZON | 11/21/2024 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/204623s013lbl.pdf#page=20 |
| Percocet | Acetaminophen; Oxycodone Hydrochloride | TABLET;ORAL | 040330 | VINTAGE PHARMS LLC | 03/04/2021 | http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/040330s052lbl.pdf |
| Percodan | Aspirin; Oxycodone Hydrochloride; Oxycodone Terephthalate | TABLET;ORAL | 007337 | ENDO PHARMS | 12/22/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/007337s058lbl.pdf#page=33 |
| Percodan | Aspirin; Oxycodone Hydrochloride | TABLET;ORAL | 007337 | ENDO PHARMS | 04/19/2024 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/007337s053lbl.pdf#page=30 |
| Perforomist | Formoterol Fumarate | SOLUTION;INHALATION | 022007 | MYLAN SPECLT | 05/29/2019 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/022007s014lbl.pdf#page=19 |
| Pertzye | Pancrelipase (Amylase;Lipase;Protease) | CAPSULE, DELAYED RELEASE;ORAL | 022175 | DIGESTIVE CARE INC | 02/28/2024 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022175s008lbl.pdf#page=13 |
| Pexeva | Paroxetine Mesylate | TABLET;ORAL | 021299 | SEBELA IRELAND LTD | 08/18/2023 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021299s035s038lbl.pdf#page=18 |
| Phenergan VC W/ Codeine | Codeine Phosphate; Phenylephrine Hydrochloride; Promethazine Hydrochloride | SYRUP;ORAL | 008306 | ANI PHARMS | 12/15/2023 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/008306s035lbl.pdf#page=66 |
| Phenergan W/ Codeine | Codeine Phosphate; Promethazine Hydrochloride | SYRUP;ORAL | 008306 | ANI PHARMS | 12/15/2023 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/008306s035lbl.pdf#page=66 |
| Plavix | Clopidogrel Bisulfate | TABLET;ORAL | 020839 | SANOFI AVENTIS US | 03/01/2021 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020839s074lbl.pdf#page=24 |
| Plegridy | Peginterferon Beta-1a | INJECTABLE;INJECTION | 125499 | BIOGEN IDEC INC | 07/28/2023 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/125499s028lbl.pdf#page=20 |
| Plenvu | Ascorbic Acid; Polyethylene Glycol 3350; Potassium Chloride; Sodium Ascorbate; Sodium Chloride; Sodium Sulfate | FOR SOLUTION;ORAL | 209381 | SALIX | 09/08/2023 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/209381s013lbl.pdf#page=18 |
| Pomalyst | Pomalidomide | CAPSULE;ORAL | 204026 | CELGENE | 02/26/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/204026s034lbl.pdf#page=33 |
| Ponstel | Mefenamic Acid | CAPSULE;ORAL | 015034 | AVION PHARMS | 12/31/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/015034s047lbl.pdf#page=20 |
| Ponvory | Ponesimod | TABLET;ORAL | 213498 | JANSSEN PHARMS | 06/05/2024 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/213498s004lbl.pdf#page=30 |
| Potiga | Ezogabine | TABLET;ORAL | 022345 | GLAXOSMITHKLINE | 05/20/2016 | http://www.fda.gov/downloads/Drugs/DrugSafety/UCM259619.pdf |
| Pradaxa | Dabigatran Etexilate Mesylate | CAPSULE;ORAL | 022512 | BOEHRINGER INGELHEIM | 06/17/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/022512s049lbl.pdf#page=27 |
| Pradaxa | Dabigatran Etexilate Mesylate | PELLETS;ORAL | 214358 | BOEHRINGER INGELHEIM | 06/17/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/214358s009lbl.pdf |
| Prepopik | Citric Acid; Magnesium Oxide; Sodium Picosulfate | FOR SOLUTION;ORAL | 202535 | FERRING PHARMS INC | 08/29/2023 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/202535s006lbl.pdf#page=15 |
| Pretomanid | Pretomanid | TABLET;ORAL | 212862 | MYLAN IRELAND LTD | 11/22/2024 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/212862s008lbl.pdf#page=27 |
| Prevacid | Lansoprazole | CAPSULE, DELAYED REL PELLETS;ORAL | 020406 | TAKEDA PHARMS USA | 08/08/2023 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/020406s095,021428s042lbl.pdf#page=45 |
| Prevacid | Lansoprazole | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE;ORAL | 021428 | TAKEDA PHARMS USA | 08/08/2023 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/020406s095,021428s042lbl.pdf#page=45 |
| Prevacid Naprapac 250 (Copackaged) | Lansoprazole; Naproxen | CAPSULE, DELAYED REL PELLETS, TABLET;ORAL | 021507 | TAKEDA PHARMS NA | 07/31/2009 | http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088694.pdf |
| Prevacid Naprapac 375 (Copackaged) | Lansoprazole; Naproxen | CAPSULE, DELAYED REL PELLETS, TABLET;ORAL | 021507 | TAKEDA PHARMS NA | 07/31/2009 | http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088694.pdf |
| Prevacid Naprapac 500 (Copackaged) | Lansoprazole; Naproxen | CAPSULE, DELAYED REL PELLETS, TABLET;ORAL | 021507 | TAKEDA PHARMS NA | 07/31/2009 | http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088694.pdf |
| Priftin | Rifapentine | TABLET;ORAL | 021024 | SANOFI AVENTIS US | 07/01/2015 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021024s017s018lbl.pdf#page=28 |
| Prilosec | Omeprazole Magnesium | FOR SUSPENSION, DELAYED RELEASE;ORAL | 022056 | COVIS | 07/18/2023 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022056s026lbl.pdf#page=34 |
| Prilosec | Omeprazole | CAPSULE, DELAYED REL PELLETS;ORAL | 019810 | ASTRAZENECA | 12/19/2016 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/019810s103,022056s020lbl.pdf#page=34 |
| Pristiq | Desvenlafaxine Succinate | TABLET, EXTENDED RELEASE;ORAL | 021992 | PF PRISM CV | 11/10/2021 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021992s047lbl.pdf#page=36 |
| Probuphine | Buprenorphine Hydrochloride | IMPLANT;IMPLANTATION | 204442 | TITAN PHARMS | 12/15/2023 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/204442s014lbl.pdf#page=47 |
| Procrit | Epoetin Alfa | VIAL; SINGLE-USE | 103234 | AMGEN | 04/30/2024 | https://www.fda.gov/media/73511/download |
| Prohance | Gadoteridol | INJECTABLE;INJECTION | 020131 | BRACCO | 08/14/2024 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/020131s042,021489s023lbl.pdf#page=32 |
| Prohance Multipack | Gadoteridol | INJECTABLE;INJECTION | 021489 | BRACCO | 08/14/2024 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/020131s042,021489s023lbl.pdf#page=32 |
| Prolia | Denosumab | INJECTABLE; SUBCUTANEOUS | 125320 | AMGEN | 05/20/2026 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/125320s224lbl.pdf#page=32 |
| Promacta | Eltrombopag Olamine | TABLET;ORAL | 022291 | NOVARTIS | 03/09/2023 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022291s037,207027s017lbl.pdf#page=35 |
| Promacta Kit | Eltrombopag Olamine | FOR SUSPENSION;ORAL | 207027 | NOVARTIS | 06/06/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/022291s041,207027s020lbl.pdf#page=36 |
| Propulsid | Cisapride Monohydrate | TABLET;ORAL | 020210 | JANSSEN PHARMS | 03/06/2000 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/Propulsid.pdf |
| Propylthiouracil | Propylthiouracil | TABLET;ORAL | 006188 | DAVA PHARMS INC | 09/19/2018 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/006188s026lbl.pdf#page=7 |
| Proquin XR | Ciprofloxacin Hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 021744 | DEPOMED INC | 08/15/2011 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/Proquin XR.pdf |
| Protonix | Pantoprazole Sodium | FOR SUSPENSION, DELAYED RELEASE;ORAL | 022020 | WYETH PHARMS | 07/18/2023 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/020987s060,022020s023lbl.pdf#page=31 |
| Protonix | Pantoprazole Sodium | TABLET, DELAYED RELEASE;ORAL | 020987 | WYETH PHARMS | 07/18/2023 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/020987s060,022020s023lbl.pdf#page=31 |
| Protopic | Tacrolimus | OINTMENT;TOPICAL | 050777 | LEO PHARMA AS | 02/25/2019 | http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088996.pdf |
| Provigil | Modafinil | TABLET;ORAL | 020717 | CEPHALON | 01/15/2015 | http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/020717s030s034s036MedGuide.pdf |
| Prozac | Fluoxetine Hydrochloride | CAPSULE;ORAL | 018936 | ELI LILLY AND CO | 08/18/2023 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/018936 s112lbl.pdf#page=26 |
| Prozac Weekly | Fluoxetine Hydrochloride | CAPSULE, DELAYED REL PELLETS;ORAL | 021235 | LILLY | 03/24/2017 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/018936s103,021235s023lbl.pdf#page=28 |
| Pyzchiva | Ustekinumab-Ttwe | INJECTABLE;SUBCUTANEOUS | 761373 | SANDOZ INC | 04/30/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/761373Orig2s000,761425Orig2s000lbl.pdf#page=39 |
| Pyzchiva | Ustekiumab-Ttwe | INJECTABLE;SUBCUTANEOUS | 761425 | SANDOZ INC | 11/18/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/761373s006,761425s005lbl.pdf#page=36 |
| Qdolo | Tramadol Hydrochloride | SOLUTION;ORAL | 214044 | ATHENA | 12/15/2023 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/214044s002lbl.pdf#page=28 |
| Qelbree | Viloxazine Hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 211964 | SUPERNUS PHARMS | 01/23/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/211964s013lbl.pdf#page=21 |
| Qmiiz ODT | Meloxicam | TABLET, ORALLY DISINTEGRATING;ORAL | 211210 | TERSERA | 04/28/2021 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/211210s002lbl.pdf#page=37 |
| Qsymia | Phentermine Hydrochloride; Topiramate | CAPSULE, EXTENDED RELEASE;ORAL | 022580 | VIVUS | 03/06/2026 | http://www.accessdata.fda.gov/drugsatfda_docs/label/2026/022580s031lbl.pdf#page=43 |
| Qtern | Dapagliflozin; Saxagliptin Hydrochloride | TABLET;ORAL | 209091 | ASTRAZENECA AB | 09/12/2023 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/209091s008lbl.pdf#page=37 |
| Qternmet XR | Dapagliflozin; METformin Hydrochloride; Saxagliptin Hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 210874 | ASTRAZENECA AB | 01/24/2020 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/210874s003lbl.pdf#page=47 |
| Qualaquin | Quinine Sulfate | CAPSULE;ORAL | 021799 | SUN PHARM INDUSTRIES | 06/19/2019 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021799s029lbl.pdf#page=26 |
| Qudexy XR | Topiramate | CAPSULE, EXTENDED RELEASE;ORAL | 205122 | UPSHER SMITH LABS | 03/28/2024 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/205122s014lbl.pdf#page=54 |
| Quillichew ER | Methylphenidate Hydrochloride | TABLET, EXTENDED RELEASE, CHEWABLE;ORAL | 207960 | NEXTWAVE PHARMS | 09/23/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/207960s018lbl.pdf#page=23 |
| Quillivant XR | Methylphenidate Hydrochloride | FOR SUSPENSION, EXTENDED RELEASE;ORAL | 202100 | NEXTWAVE | 09/23/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/202100s024lbl.pdf#page=23 |
| Quviviq | Daridorexant | TABLET; ORAL | 214985 | IDORSIA PHARMACEUTICALS LTD. | 09/30/2024 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/214985s010s012lbl.pdf#page=24 |
| Raldesy | Trazodone Hydrochloride, Usp | SOLUTION;ORAL | 218637 | VALIDUS PHARMACEUTICALS LLC | 06/24/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/218637s003lbl.pdf#page=14 |
| Rapamune | Sirolimus | SOLUTION;ORAL | 021083 | PF PRISM CV | 01/02/2020 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021083s067,021110s085lbl.pdf#page=43 |
| Rapamune | Sirolimus | TABLET;ORAL | 021110 | PF PRISM CV | 08/09/2021 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021110s086lbl.pdf#page=43 |
| Ravicti | Glycerol Phenylbutyrate | LIQUID;ORAL | 203284 | HORIZON THERAP | 09/03/2021 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/203284s012lbl.pdf#page=27 |
| Rebetol | Ribavirin | SOLUTION;ORAL | 021546 | SCHERING | 03/16/2022 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020903s057,021546s013lbl.pdf#page=26 |
| Rebetol | Ribavirin | CAPSULE;ORAL | 020903 | MERCK SHARP DOHME | 03/16/2022 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020903s057,021546s013lbl.pdf#page=26 |
| Rebif | Interferon Beta-1a | SYRINGE | 103780 | SERONO INC | 07/28/2023 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/103780s5214lbl.pdf#page=16 |
| Reclast | Zoledronic Acid | INJECTABLE;INTRAVENOUS | 021817 | NOVARTIS | 02/03/2026 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/021817s032lbl.pdf#page=34 |
| Recorlev | Levoketoconazole | TABLET;ORAL | 214133 | STRONGBRIDGE | 08/16/2023 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/214133s003lbl.pdf#page=3 |
| Reglan | Metoclopramide Hydrochloride | INJECTABLE;INJECTION | 017862 | HIKMA | 02/09/2026 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/017862s64lbl.pdf#page=17 |
| Reglan ODT | Metoclopramide Hydrochloride | TABLET, ORALLY DISINTEGRATING;ORAL | 021793 | MEDA PHARMS | 11/30/2011 | http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021793s011mg.pdf |
| Regranex | Becaplermin | GEL; TOPICAL | 103691 | SMITH AND NEPHEW | 08/26/2019 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/103691s5138lbl.pdf#page=8 |
| Relexxii | Methylphenidate Hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 216117 | VERTICAL PHARMACEUTICALS | 09/23/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/216117s003lbl.pdf#page=25 |
| Relistor | Methylnaltrexone Bromide | SOLUTION;SUBCUTANEOUS | 021964 | SALIX PHARMS | 03/14/2018 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021964s019,208271s003lbl.pdf#page=24 |
| Relistor | Methylnaltrexone Bromide | TABLET;ORAL | 208271 | SALIX | 03/14/2018 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021964s019,208271s003lbl.pdf#page=24 |
| Remeron | Mirtazapine | TABLET;ORAL | 020415 | ORGANON USA INC | 11/18/2021 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020415s038,021208s028lbl.pdf#page=23 |
| Remeron Soltab | Mirtazapine | TABLET, ORALLY DISINTEGRATING;ORAL | 021208 | ORGANON USA INC | 11/18/2021 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020415s038,021208s028lbl.pdf#page=23 |
| Remicade | Infliximab | VIAL | 103772 | CENTOCOR INC | 02/28/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/103772s5412lbl.pdf#page=50 |
| Renflexis | Infliximab-Abda | INJECTABLE;INJECTION | 761054 | SAMSUNG BIOEPIS CO LTD | 10/28/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/761054s041lbl.pdf#page=55 |
| Restoril | Temazepam | CAPSULE;ORAL | 018163 | SPECGX LLC | 01/13/2023 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/018163s071lbl.pdf#page=17 |
| Retacrit | Epoetin Alfa-Epbx | INJECTABLE;INJECTION | 125545 | HOSPIRA INC | 06/04/2024 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/125545s005lbl.pdf#page=31 |
| Revlimid | Lenalidomide | CAPSULE;ORAL | 021880 | CELGENE | 03/24/2023 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021880s067lbl.pdf#page=48 |
| Revuforj | Revumenib Citrate | TABLET | 218944 | SYNDAX PHARMACEUTICALS, INC. | 10/24/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/218944s003lbl.pdf#page=25 |
| Rexulti | Brexpiprazole | TABLET;ORAL | 205422 | OTSUKA | 05/04/2026 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/205422s017lbl.pdf#page=40 |
| Reyvow | Lasmiditan Succinate | TABLET;ORAL | 211280 | ELI LILLY AND CO | 09/15/2022 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/211280s008lbl.pdf#page=15 |
| Rezira | Hydrocodone Bitartrate; Pseudoephedrine Hydrochloride | SOLUTION;ORAL | 022442 | PERSION | 06/28/2018 | http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/022442s010lbl.pdf#page=26 |
| Riabni | Rituximab-Arrx | INJECTABLE;INJECTION | 761140 | AMGEN INC | 10/06/2026 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/761140s005lbl.pdf#page=54 |
| Rinvoq | Upadacitinib | TABLET, EXTENDED RELEASE;ORAL | 211675 | ABBVIE INC | 07/10/2026 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/218347Orig1s008,211675Orig1s034lbl.pdf#page=78 |
| Ritalin | Methylphenidate Hydrochloride | TABLET;ORAL | 010187 | NOVARTIS | 02/04/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/010187s094lbl.pdf#page=15 |
| Ritalin LA | Methylphenidate Hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 021284 | NOVARTIS | 09/23/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/021284s050lbl.pdf#page=21 |
| Ritalin-SR | Methylphenidate Hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 018029 | NOVARTIS | 11/19/2019 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/010187s091,018029s059lbl.pdf#page=13 |
| Rituxan | Rituximab | SOLUTION;INTRAVENOUS | 103705 | GENENTECH | 12/17/2021 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/103705s5465lbl.pdf#page=56 |
| Rituxan Hycela | Rituximab; Hyaluronidase (Human Recombinant) | SOLUTION;SUBCUTANEOUS | 761064 | GENENTECH INC | 06/10/2021 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/761064s013lbl.pdf#page=28 |
| Rivaroxaban | Rivaroxaban | SUSPENSION | 221033 | ROSEMONT PHARMACEUTICALS HOLDINGS, INC. | 10/20/2026 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/221033Orig1s000lbl.pdf#page=57 |
| Romvimza | Vimseltinib | CAPSULE;ORAL | 219304 | DECIPHERA PHARMACEUTICALS LTD | 02/14/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/219304s000lbl.pdf#page=18 |
| Roxicodone | Oxycodone Hydrochloride | TABLET;ORAL | 021011 | SPECGX LLC | 04/19/2024 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021011s013lbl.pdf#page=30 |
| Roxybond | Oxycodone Hydrochloride | TABLET;ORAL | 209777 | OHEMO LIFE | 04/19/2024 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/209777s008lbl.pdf#page=38 |
| Rozerem | Ramelteon | TABLET;ORAL | 021782 | TAKEDA PHARMS USA | 11/03/2021 | http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021782s022lbl.pdf#page=17 |
| Ruxience | Rituximab-Pvvr | INJECTABLE;INJECTION | 761103 | PFIZER INC | 10/06/2026 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/761103s020lbl.pdf#page=50 |
| Ruzurgi | Amifampridine | TABLET;ORAL | 209321 | JACOBUS PHARM CO INC | 08/21/2020 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/209321s000lbl.pdf#page=15 |
| Rybelsus | Semaglutide | TABLET;ORAL | 213051 | NOVO | 10/17/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/213051s024,s028s029lbl.pdf#page=27 |
| Rybelsus | Semaglutide | TABLET;ORAL | 213182 | NOVO NORDISK INC | 01/16/2020 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/213182s000,213051s001lbl.pdf#page=23 |
| Sabril | Vigabatrin | FOR SOLUTION;ORAL | 022006 | LUNDBECK PHARMS LLC | 10/20/2021 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020427s025,022006s026lbl.pdf#page=26 |
| Sabril | Vigabatrin | TABLET;ORAL | 020427 | LUNDBECK PHARMS LLC | 10/20/2021 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020427s025,022006s026lbl.pdf#page=26 |
| Samsca | Tolvaptan | TABLET;ORAL | 022275 | OTSUKA | 04/22/2021 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022275s017lbl.pdf#page=19 |
| Sarafem | Fluoxetine Hydrochloride | TABLET;ORAL | 021860 | APIL | 09/20/2021 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021860s015lbl.pdf#page=32 |
| Savaysa | Edoxaban Tosylate | TABLET;ORAL | 206316 | DAIICHI SANKYO INC | 10/18/2023 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/206316s019lbl.pdf#page=35 |
| Savella | Milnacipran Hydrochloride | TABLET;ORAL | 022256 | ALLERGAN | 09/10/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/022256s031lbl.pdf#page=31 |
| Saxenda | Liraglutide Recombinant | SOLUTION;SUBCUTANEOUS | 206321 | NOVO | 10/14/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/206321s022lbl.pdf#page=29 |
| Seglentis | Celecoxib; Tramadol Hydrochloride | TABLET;ORAL | 213426 | KOWA PHARMS | 11/21/2024 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/213426s003lbl.pdf#page=57 |
| Segluromet | Ertugliflozin; METformin Hydrochloride | TABLET;ORAL | 209806 | MERCK SHARP DOHME | 08/18/2026 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/209806s015s013lbl.pdf#page=34 |
| Selarsdi | Ustekinumab-Aekn | INJECTABLE;SUBCUTANEOUS | 761343 | TEVA PHARMACEUTICALS | 04/30/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/761343s004lbl.pdf#page=32 |
| Selzentry | Maraviroc | SOLUTION;ORAL | 208984 | VIIV HLTHCARE | 10/30/2020 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022128s019,208984s002lbl.pdf#page=43 |
| Selzentry | Maraviroc | TABLET;ORAL | 022128 | VIIV HLTHCARE | 10/30/2020 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022128s019,208984s002lbl.pdf#page=43 |
| Semaglutide | Semaglutide | TABLET | 218316 | NOVO NORDISK INC | 03/19/2026 | http://www.accessdata.fda.gov/drugsatfda_docs/label/2026/218316s005lbl.pdf#page=51 |
| Serevent | Salmeterol Xinafoate | POWDER;INHALATION | 020692 | GLAXOSMITHKLINE | 07/22/2019 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020692s047lbl.pdf#page=35 |
| Seroquel | Quetiapine Fumarate | TABLET;ORAL | 020639 | ASTRAZENECA | 01/22/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/020639s074lbl.pdf#page=49 |
| Seroquel XR | Quetiapine Fumarate | TABLET, EXTENDED RELEASE;ORAL | 022047 | ASTRAZENECA | 01/22/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/022047s048lbl.pdf#page=53 |
| Sertraline | Sertraline Hydrochloride | CAPSULE;ORAL | 215133 | ALMATICA PHARMA | 10/06/2026 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/215133s004lbl.pdf#page=26 |
| Signifor | Pasireotide Diaspartate | SOLUTION;SUBCUTANEOUS | 200677 | RECORDATI RARE | 01/15/2020 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/200677s006lbl.pdf#page=15 |
| Siklos | Hydroxyurea | TABLET;ORAL | 208843 | ADDMEDICA SAS | 11/28/2023 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/208843s004lbl.pdf#page=18 |
| Silenor | Doxepin Hydrochloride | TABLET;ORAL | 022036 | CURRAX | 10/29/2020 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022036s006lbl.pdf#page=19 |
| Siliq | Brodalumab | INJECTABLE;INJECTION | 761032 | VALEANT LUXEMBOURG | 02/27/2026 | http://www.accessdata.fda.gov/drugsatfda_docs/label/2026/761032s020lbl.pdf#page=14 |
| Simlandi | Adalimumab | INJECTION | 761299 | ALVOTECH USA INC. | 10/16/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/761299s025lbl.pdf#page=48 |
| Simponi | Golimumab | INJECTABLE; INJECTION | 125289 | CENTOCOR ORTHO BIOTECH INC | 10/22/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/125289s158lbl.pdf#page=41 |
| Simponi Aria | Golimumab | INJECTABLE; INJECTION | 125433 | JANSSEN BIOTECH | 04/18/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/125289Orig1s155,125433Orig1s036Correctedlbl.pdf#page=76 |
| Sinequan | Doxepin Hydrochloride | CAPSULE;ORAL | 016798 | PFIZER | 07/14/2014 | http://www.fda.gov/downloads/Drugs/DrugSafety/ucm089129.pdf |
| Sinequan (Doxepin Hydrochloride) | Doxepin Hydrochloride | CONCENTRATE | 017516 | PFIZER INC. | 07/03/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/016798s057,017516s026lbl.pdf#page=19 |
| Sinequan (Doxepin Hydrochloride) | Doxepin Hydrochloride | CAPSULE | 016798 | PFIZER INC. | 07/03/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/016798s057,017516s026lbl.pdf#page=19 |
| Singulair | Montelukast Sodium | GRANULE;ORAL | 021409 | MERCK | 02/22/2021 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020829s074,020830s0760,021409s052lbl.pdf#page=25 |
| Singulair | Montelukast Sodium | TABLET;ORAL | 020829 | MSD MERCK CO | 02/22/2021 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020829s074,020830s076,021409s052lbl.pdf#page=25 |
| Singulair | Montelukast Sodium | TABLET, CHEWABLE;ORAL | 020830 | MSD MERCK CO | 02/22/2021 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020829s074,020830s0760,021409s052lbl.pdf#page=25 |
| Sirturo | Bedaquiline Fumarate | TABLET;ORAL | 204384 | JANSSEN THERAP | 07/28/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/204384s020lbl.pdf#page=33 |
| Skyrizi | Risankizumab-Rzaa | INJECTABLE;SUBCUTANEOUS | 761262 | ABBVIE INC | 06/16/2026 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/761262s015lbl.pdf#page=42 |
| Skyrizi | Risankizumab-Rzaa | INJECTABLE;INJECTION | 761105 | ABBVIE INC | 06/16/2026 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/761105s044lbl.pdf#page=42 |
| Sodium Oxybate | Sodium Oxybate | SOLUTION;ORAL | 202090 | HIKMA | 01/03/2022 | http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/202090lbl.pdf#page=18 |
| Sohonos | Paloverotene | CAPSULE;ORAL | 215559 | IPSEN BIOPHARMACEUTICALS | 08/16/2023 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/215559s000lbl.pdf#page=20 |
| Solaraze | Diclofenac Sodium | GEL;TOPICAL | 021005 | FOUGERA PHARMS | 11/14/2022 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021005s024lbl.pdf#page=22 |
| Solaraze | Diclofenac Sodium | GEL;TOPICAL | 021005 | FOUGERA PHARMS | 04/28/2021 | http://www.fda.gov/downloads/Drugs/DrugSafety/UCM501655.pdf |
| Soliqua 100/33 | Insulin Glargine; Lixisenatide | SOLUTION;SUBCUTANEOUS | 208673 | SANOFI-AVENTIS US | 03/12/2026 | http://www.accessdata.fda.gov/drugsatfda_docs/label/2026/208673s023lbl.pdf#page=30 |
| Soliris | Eculizumab | INJECTABLE; IV (INFUSION) | 125166 | ALEXION PHARM | 07/10/2026 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/125166s454lbl.pdf#page=37 |
| Soltamox | Tamoxifen Citrate | SOLUTION;ORAL | 021807 | MAYNE PHARMA INC | 04/08/2019 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021807s006lbl.pdf#page=36 |
| Sonata | Zaleplon | CAPSULE;ORAL | 020859 | PFIZER | 08/18/2019 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020859s016lbl.pdf#page=21 |
| Soriatane | Acitretin | CAPSULE;ORAL | 019821 | STIEFEL LABS INC | 02/22/2023 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/019821s029lbl.pdf#page=30 |
| Sotret | Isotretinoin | CAPSULE;ORAL | 076041 | SUN PHARM INDS LTD | 04/12/2012 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/Sotret.pdf |
| Sotyktu | Deucravacitinib | TABLET;ORAL | 214958 | BRISTOL MYERS SQUIBB | 07/10/2026 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/214958s006sdn685lbl.pdf#page=23 |
| Spevigo | Spesolimab-Sbzo | INJECTABLE;INTRAVENOUS | 761244 | Boehringer Ingelheim Pharmaceuticals, Inc | 10/21/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/761244s007lbl.pdf#page=17 |
| Spravato | Esketamine Hydrochloride | SPRAY;NASAL | 211243 | JANSSEN PHARMS | 09/22/2026 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/211243s026lbl.pdf |
| Spritam | Levetiracetam | TABLET, FOR SUSPENSION;ORAL | 207958 | APRECIA PHARMS | 06/14/2024 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/207958s023lbl.pdf#page=36 |
| Sprix | Ketorolac Tromethamine | SPRAY, METERED;NASAL | 022382 | ZYLA | 11/21/2024 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/022382s022lbl.pdf#page=22 |
| Starjemza | Ustekinumab-Hmny | INJECTABLE;SUBCUTANEOUS,INTRAVENOUS | 761419 | BIO-THERA SOLUTIONS, LTD. | 05/22/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/761419s000lbl.pdf#page=36 |
| Stavzor | Valproic Acid | CAPSULE, DELAYED RELEASE;ORAL | 022152 | BIONPHARMA INC | 03/31/2026 | http://www.accessdata.fda.gov/drugsatfda_docs/label/2026/022152s010lbl.pdf#page=44 |
| Steglatro | Ertugliflozin | TABLET;ORAL | 209803 | MERCK SHARP DOHME | 12/20/2024 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/209803Ss008lbledt.pdf#page=25 |
| Steglujan | Ertugliflozin; Sitagliptin Phosphate | TABLET;ORAL | 209805 | MERCK SHARP DOHME | 12/20/2024 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/209805s017lbledt.pdf#page=31 |
| Stelara | Ustekinumab | INJECTABLE;INJECTION | 761044 | JANSSEN BIOTECH | 09/01/2026 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/761044s021lbl.pdf#page=42 |
| Stelara | Ustekinumab | INJECTABLE; INJECTION | 125261 | CENTOCOR ORTHO BIOTECH INC | 07/16/2026 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/125261s174lbl.pdf#page=39 |
| Steqeyma | Ustekinumab-Stba | INJECTABLE;SUBCUTANEOUS | 761338 | CELLTRION | 06/13/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/761338Orig1s003lbl.pdf#page=37 |
| Stoboclo | Denosumab | INJECTABLE;SOLUTION | 761404 | CELLTRION, INC. | 10/29/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/761404s000lbl.pdf#page=33 |
| Strattera | Atomoxetine Hydrochloride | CAPSULE;ORAL | 021411 | LILLY | 07/10/2026 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/021411s053lbl.pdf#page=25 |
| Striverdi Respimat | Olodaterol Hydrochloride | SPRAY, METERED;INHALATION | 203108 | BOEHRINGER INGELHEIM | 05/29/2019 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/striverdi respimatMedGuide2016.pdf |
| Sublocade | Buprenorphine | SOLUTION, EXTENDED RELEASE;SUBCUTANEOUS | 209819 | INDIVIOR INC | 02/21/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/209819s031lbl.pdf#page=45 |
| Suboxone | Buprenorphine Hydrochloride; Naloxone Hydrochloride | FILM;BUCCAL, SUBLINGUAL | 022410 | INDIVIOR INC | 06/17/2022 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022410s046s047lbl.pdf#page=35 |
| Suboxone | Buprenorphine Hydrochloride; Naloxone Hydrochloride | TABLET;SUBLINGUAL | 020733 | INDIVIOR INC | 06/17/2022 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020733s031s032lbl.pdf#page=32 |
| Subsys | Fentanyl | SPRAY;SUBLINGUAL | 202788 | BTCP PHARMA | 12/03/2021 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/202788s023lbl.pdf#page=40 |
| Subutex | Buprenorphine Hydrochloride | TABLET;SUBLINGUAL | 020732 | INDIVIOR INC | 06/17/2022 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020732s027s028lbl.pdf#page=29 |
| Subvenite | Lamotrigine | SUSPENSION | 218879 | OWP PHARMACEUTICALS INC | 09/16/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/218879s000lbl.pdf#page=48 |
| Suclear | Magnesium Sulfate; Polyethylene Glycol 3350; Potassium Chloride; Potassium Sulfate; Sodium Bicarbonate; Sodium Chloride; Sodium Sulfate | SOLUTION;ORAL | 203595 | BRAINTREE LABS | 08/15/2013 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/203595s000lbl.pdf#page=13 |
| Suflave | Polyethylene Glycol 3350; Sodium Sulfate; Potassium Chloride; Magnesium Sulfate; Sodium Chloride | SOLUTION;ORAL | 215344 | BRAINTREE LABORATORIES | 06/15/2023 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/215344s000lbl.pdf#page=14 |
| Sunosi | Solriamfetol Hydrochloride | TABLET;ORAL | 211230 | JAZZ | 06/28/2023 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/211230s009lbl.pdf#page=23 |
| Supprelin LA | Histrelin Acetate | IMPLANT;SUBCUTANEOUS | 022058 | ENDO PHARM | 09/23/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/022058s020lbl.pdf#page=25 |
| Suprep Bowel Prep Kit | Magnesium Sulfate; Potassium Sulfate; Sodium Sulfate | SOLUTION;ORAL | 022372 | BRAINTREE LABS | 11/18/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/022372s016lbl.pdf#page=14 |
| Surmontil | Trimipramine Maleate | CAPSULE;ORAL | 016792 | ODYSSEY PHARMS | 09/30/2014 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/016792s037lbl.pdf#page=12 |
| Sustol | Granisetron | INJECTION, EXTENDED RELEASE;SUBCUTANEOUS | 022445 | HERON THERAPS INC | 02/23/2026 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/022445s014lbl.pdf#page=17 |
| Susvimo | Ranibizumab | INJECTION | 761197 | GENENTECH INC | 09/05/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/761197s008lbl.pdf#page=40 |
| Sutab | Magnesium Sulfate; Potassium Chloride; Sodium Sulfate | TABLET;ORAL | 213135 | BRAINTREE LABS | 10/24/2023 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/213135s004lbl.pdf#page=15 |
| Sutent | Sunitinib Malate | CAPSULE;ORAL | 021938 | CPPI CV | 08/30/2021 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021938s039lbledt.pdf#page=34 |
| Sylatron | Peginterferon Alfa-2b | VIAL | 103949 | SCHERING | 12/21/2018 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/103949s5312lbl.pdf#page=13 |
| Symbravo | Meloxicam, Rizatriptan | TABLET;ORAL | 215431 | AXSOME THERAPEUTICS, INC | 01/30/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/215431s000lbl.pdf#page=27 |
| Symbyax | Fluoxetine Hydrochloride; Olanzapine | CAPSULE;ORAL | 021520 | LILLY | 01/22/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/021520s056lbl.pdf#page=42 |
| Symlin | Pramlintide Acetate | INJECTABLE;SUBCUTANEOUS | 021332 | ASTRAZENECA AB | 12/18/2019 | http://www.fda.gov/downloads/Drugs/DrugSafety/ucm089141.pdf |
| Sympazan | Clobazam | FILM;ORAL | 210833 | AQUESTIVE | 03/12/2024 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/210833s004lbl.pdf#page=26 |
| Symproic | Naldemedine Tosylate | TABLET;ORAL | 208854 | BDSI | 07/15/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/208854s007lbl.pdf#page=14 |
| Synalgos-DC | Aspirin; Caffeine; Dihydrocodeine Bitartrate | CAPSULE;ORAL | 011483 | SUN PHARM INDUSTRIES | 12/22/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/011483s038lbl.pdf#page=51 |
| Synarel | Nafarelin Acetate | SPRAY, METERED;NASAL | 019886 | PFIZER | 11/24/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/019886s040lbl.pdf#page=29 |
| Synjardy | Empagliflozin; METformin Hydrochloride | TABLET;ORAL | 206111 | BOEHRINGER INGELHEIM | 08/18/2026 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/206111s050lbl.pdf#page=44 |
| Synjardy XR | Empagliflozin; METformin Hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 208658 | BOEHRINGER INGELHEIM | 08/18/2026 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/208658s038lbl.pdf#page=44 |
| Synribo | Omacetaxine Mepesuccinate | POWDER;SUBCUTANEOUS | 203585 | TEVA PHARMS INTL | 05/12/2021 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/203585Orig1s008lbl.pdf#page=18 |
| Tafinlar | Dabrafenib Mesylate | CAPSULE;ORAL | 202806 | NOVARTIS | 01/30/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/202806s036,217514s010lbl.pdf#page=46 |
| Tafinlar | Dabrafenib | TABLET;ORAL | 217514 | NOVARTIS PHARMACEUTICALS | 01/30/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/202806s036,217514s010lbl.pdf#page=46 |
| Taltz | Ixekizumab | INJECTABLE;INJECTION | 125521 | ELI LILLY AND CO | 07/27/2022 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/125521s024lbl.pdf#page=21 |
| Talvey | Talquetamab-Tgvs | INJECTABLE; SUBCUTANEOUS | 761342 | JANSSEN BIOTECH | 10/02/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/761342s016lbl.pdf#page=30 |
| Tanzeum | Albiglutide | INJECTABLE;INJECTION | 125431 | GLAXOSMITHKLINE LLC | 12/20/2017 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/125431s019lbl.pdf#page=36 |
| Targiniq | Naloxone Hydrochloride; Oxycodone Hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 205777 | PURDUE PHARMA LP | 09/18/2018 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/205777s010s011lbl.pdf#page=47 |
| Tascenso ODT | Fingolimod LAuryl Sulfate | TABLET, ORALLY DISINTEGRATING;ORAL | 214962 | HANDA NEUROSCIENCE, LTD | 07/10/2026 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/214962s005lbl.pdf#page=24 |
| Tasigna | Nilotinib Hydrochloride | CAPSULE;ORAL | 022068 | NOVARTIS | 02/08/2024 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022068s035s036lbl.pdf#page=36 |
| Tavneos | Avacopan | CAPSULE;ORAL | 214487 | CHEMOCENTRYX | 06/03/2024 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/214487s000lbl.pdf#page=17 |
| Tazverik | Tazemetostat Hydrobromide | TABLET;ORAL | 211723 | EPIZYME INC | 11/16/2023 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/211723s004lbl.pdf#page=17 |
| Tazverik | Tazemetostat Hydrobromide | TABLET;ORAL | 213400 | EPIZYME INC | 06/18/2020 | http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/213400s000lbl.pdf#page=17 |
| Tecentriq | Atezolizumab | INJECTABLE;INJECTION | 761034 | GENENTECH INC | 10/09/2026 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/761034s065lbl.pdf#page=83 |
| Tecentriq | Atezolizumab | INJECTABLE; INJECTION | 761041 | GENENTECH INC | 10/18/2016 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/761041s000lbl.pdf#page=22 |
| Tecentriq Hybreza | Atezolizumab, Hyaluronidase (Human Recombinant) | INJECTABLE;SUBCUTANEOUS | 761347 | GENENTECH INC | 10/09/2026 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/761347s011lbl.pdf#page=91 |
| Technivie | Ombitasvir; Paritaprevir; Ritonavir | TABLET;ORAL | 207931 | ABBVIE INC | 12/06/2019 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/207931s013lbl.pdf#page=39 |
| Tecvayli | Teclistamab-Cqyv | INJECTABLE; SUBCUTANEOUS | 761291 | JANSSEN BIOTECH | 03/05/2026 | http://www.accessdata.fda.gov/drugsatfda_docs/label/2026/0761291s018lbl.pdf#page=37 |
| Tegretol | Carbamazepine | SUSPENSION;ORAL | 018927 | NOVARTIS | 09/30/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/018927Orig1s061;016608Orig1s122;020234Orig1s055lbl.pdf#page=20 |
| Tegretol | Carbamazepine | TABLET, CHEWABLE;ORAL | 018281 | NOVARTIS | 03/20/2018 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/016608s115_018281_s058_018927s055_020234_s047.pdf#page=19 |
| Tegretol | Carbamazepine | TABLET;ORAL | 016608 | NOVARTIS | 09/30/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/018927Orig1s061;016608Orig1s122;020234Orig1s055lbl.pdf#page=20 |
| Tegretol-XR | Carbamazepine | TABLET, EXTENDED RELEASE;ORAL | 020234 | NOVARTIS | 09/30/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/018927Orig1s061;016608Orig1s122;020234Orig1s055lbl.pdf#page=20 |
| Tegsedi | Inotersen Sodium | SOLUTION;SUBCUTANEOUS | 211172 | AKCEA THERAPS | 01/12/2024 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/211172s010lbl.pdf#page=28 |
| Testim | Testosterone | GEL;TRANSDERMAL | 021454 | AUXILIUM PHARMS LLC | 07/11/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/021454s036lbl.pdf#page=24 |
| Testosterone | Testosterone | GEL;TRANSDERMAL | 202763 | ANI PHARMS | 10/25/2016 | http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/202763s000mg.pdf |
| Testosterone Cypionate Injection | Testosterone Cypionate | INJECTABLE;INTRAMUSCULAR | 216318 | SLAYBACK PHARMA LLC | 07/11/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/216318s005lbl.pdf#page=18 |
| Tevimbra | Tislelizumab-Jsgr | INJECTABLE;INTRAVENOUS | 761417 | BEIGENE, LTD | 09/05/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/761417Orig1s000correctedlbl.pdf#page=22 |
| Tevimbra | Tislelizumab-Jsgr | INJECTABLE;INJECTION | 761232 | BEIGENE | 08/27/2026 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/761232s018lbl.pdf#page=39 |
| Tevimbra | Tislelizumab-Jsgr | INJECTABLE;INTRAVENOUS | 761380 | BEIGENE, LTD | 03/03/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/761380s000lbl.pdf#page=26 |
| Thalomid | Thalidomide | CAPSULE;ORAL | 020785 | CELGENE | 09/04/2026 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/020785s074lbl.pdf#page=21 |
| Tibsovo | Ivosidenib | TABLET;ORAL | 211192 | SERVIER | 10/24/2023 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/211192s011lbl.pdf#page=38 |
| Tikosyn | Dofetilide | CAPSULE;ORAL | 020931 | PFIZER | 08/08/2019 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020931s017lbl.pdf#page=27 |
| Tivdak | Tisotumab Vedotin-Tftv | INJECTABLE;INJECTION | 761208 | SEAGEN | 11/12/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/761208s010lbl.pdf#page=27 |
| Tivorbex | Indomethacin | CAPSULE;ORAL | 204768 | GENUS | 04/28/2021 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/204768s008lbl.pdf#page=25 |
| Tlando | Testosterone Undecanoate | CAPSULE | 208088 | VERITY PHARMACEUTICALS INC | 07/11/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/208088s002lbl.pdf#page=17 |
| Tofidence | Tocilizumab-Bavi | INJECTABLE;INTRAVENOUS | 761354 | BIOGEN MA | 12/03/2024 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/761354s004lbl.pdf#page=55 |
| Tofranil | Imipramine Hydrochloride | TABLET;ORAL | 087846 | SPECGX LLC | 06/29/2017 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/087846s028,087844s027,087845s027lbl.pdf#page=3 |
| Tofranil-Pm | Imipramine Pamoate | CAPSULE;ORAL | 017090 | SPECGX LLC | 07/28/2014 | http://www.fda.gov/downloads/Drugs/DrugSafety/UCM326090.pdf |
| Tolectin | Tolmetin Sodium | TABLET;ORAL | 017628 | ORTHO MCNEIL JANSSEN | 01/22/2008 | http://www.fda.gov/downloads/Drugs/DrugSafety/ucm089162.pdf |
| Tolectin 600 | Tolmetin Sodium | TABLET;ORAL | 017628 | ORTHO MCNEIL JANSSEN | 01/22/2008 | http://www.fda.gov/downloads/Drugs/DrugSafety/ucm089162.pdf |
| Tolectin DS | Tolmetin Sodium | CAPSULE;ORAL | 018084 | ORTHO MCNEIL JANSSEN | 01/22/2008 | http://www.fda.gov/downloads/Drugs/DrugSafety/ucm089162.pdf |
| Topamax | Topiramate | TABLET;ORAL | 020505 | JANSSEN PHARMS | 03/06/2026 | http://www.accessdata.fda.gov/drugsatfda_docs/label/2026/020505s068lbl.pdf#page=55 |
| Topamax | Topiramate | CAPSULE;ORAL | 020844 | JANSSEN PHARMS | 03/06/2026 | http://www.accessdata.fda.gov/drugsatfda_docs/label/2026/020844s059lbl.pdf#page=55 |
| Topamax Sprinkle | Topiramate | CAPSULE;ORAL | 020844 | JANSSEN PHARMS | 05/03/2023 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/020505s065,020844s056lbl.pdf#page=56 |
| Toradol | Ketorolac Tromethamine | TABLET;ORAL | 019645 | ROCHE PALO | 03/26/2013 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/019645s019lbl.pdf#page=23 |
| Tracleer | Bosentan | TABLET;ORAL | 021290 | ACTELION | 11/05/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/021290s048,209279s015lbl.pdf#page=31 |
| Tracleer | Bosentan | TABLET, FOR SUSPENSION;ORAL | 209279 | ACTELION | 11/05/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/021290s048,209279s015lbl.pdf#page=31 |
| Tradjenta | Linagliptin | TABLET;ORAL | 201280 | BOEHRINGER INGELHEIM | 06/20/2023 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/201280s027lbl.pdf#page=16 |
| Tranxene | Clorazepate Dipotassium | CAPSULE;ORAL | 017105 | RECORDATI RARE | 01/13/2023 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/017105s085lbl.pdf#page=14 |
| Tranxene | Clorazepate Dipotassium | TABLET;ORAL | 017105 | RECORDATI RARE | 01/13/2023 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/017105s085lbl.pdf#page=14 |
| Tranxene SD | Clorazepate Dipotassium | TABLET;ORAL | 017105 | RECORDATI RARE | 01/13/2023 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/017105s085lbl.pdf#page=14 |
| Trazodone Hydrochloride | Trazodone Hydrochloride | TABLET;ORAL | 071196 | APOTEX INC | 04/20/2020 | http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/071196s062lbl.pdf#page=3 |
| Trelegy Ellipta | Fluticasone Furoate; Umeclidinium Bromide; Vilanterol Trifenatate | POWDER;INHALATION | 209482 | GLAXOSMITHKLINE | 06/02/2023 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/209482s000lbl.pdf#page=33 |
| Tremfya | Guselkumab | INJECTABLE;INJECTION | 761061 | JANSSEN BIOTECH | 05/28/2026 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/761061s034lbl.pdf#page=47 |
| Treximet | Naproxen Sodium; Sumatriptan Succinate | TABLET;ORAL | 021926 | CURRAX | 11/21/2024 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/021926s019lbl.pdf#page=32 |
| Tridione | Trimethadione | SOLUTION;ORAL | 005856 | ABBVIE | 06/07/2016 | http://www.fda.gov/downloads/Drugs/DrugSafety/UCM308402.pdf |
| Tridione | Trimethadione | CAPSULE;ORAL | 005856 | ABBVIE | 06/07/2016 | http://www.fda.gov/downloads/Drugs/DrugSafety/UCM308402.pdf |
| Tridione | Trimethadione | TABLET;ORAL | 005856 | ABBVIE | 06/07/2016 | http://www.fda.gov/downloads/Drugs/DrugSafety/UCM308402.pdf |
| Trijardy XR | Empagliflozin; Linagliptin; METformin Hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 212614 | BOEHRINGER INGELHEIM | 08/18/2026 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/212614s032lbl.pdf#page=44 |
| Trikafta | Elexacaftor, Tezacaftor, Ivacaftor) | TABLET | 212273 | VERTEX PHARMACEUTICALS INC | 03/27/2026 | http://www.accessdata.fda.gov/drugsatfda_docs/label/2026/212273s014lbl.pdf#page=30 |
| Trikafta | Ivacaftor, Elexacaftor, Tezacaftor | GRANULE | 217660 | VERTEX PHARMACEUTICALS INC | 03/27/2026 | http://www.accessdata.fda.gov/drugsatfda_docs/label/2026/217660s008lbl.pdf#page=30 |
| Trileptal | Oxcarbazepine | SUSPENSION;ORAL | 021285 | NOVARTIS | 09/23/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/021014s049,021285s041lbl.pdf#page=27 |
| Trileptal | Oxcarbazepine | TABLET;ORAL | 021014 | NOVARTIS | 09/23/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/021014s049,021285s041lbl.pdf#page=27 |
| Trintellix | Vortioxetine Hydrobromide | TABLET;ORAL | 204447 | TAKEDA PHARMS USA | 08/23/2023 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/204447s026lbl.pdf#page=33 |
| Triptodur Kit | Triptorelin Pamoate | FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | 208956 | ARBOR PHARMS LLC | 09/23/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/208956s014lbl.pdf#page=13 |
| Triumeq | Abacavir Sulfate; Dolutegravir Sodium; LAmivudine | TABLET;ORAL | 205551 | VIIV HLTHCARE | 10/28/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/205551s034lbl.pdf#page=56 |
| Triumeq Pd | Abacavir Sulfate; Dolutegravir Sodium; LAmivudine | SUSPENSION;ORAL | 215413 | VIIV HLTHCARE | 10/28/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/215413s005lbl.pdf#page=56 |
| Trizivir | Abacavir Sulfate; LAmivudine; Zidovudine | TABLET;ORAL | 021205 | VIIV HLTHCARE | 02/17/2021 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021205s038lbl.pdf#page=34 |
| Trokendi XR | Topiramate | CAPSULE, EXTENDED RELEASE;ORAL | 201635 | SUPERNUS PHARMS | 03/06/2026 | http://www.accessdata.fda.gov/drugsatfda_docs/label/2026/201635s039lbl.pdf#page=43 |
| Troxyca ER | Naltrexone Hydrochloride; Oxycodone Hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 207621 | PFIZER | 05/26/2017 | http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/207621s004lbl.pdf#page=32 |
| Trudhesa | Dihydroergotamine Mesylate | SPRAY, METERED;NASAL | 213436 | IMPEL NEUROPHARMA | 09/02/2021 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/213436s000lbl.pdf#page=22 |
| Trulance | Plecanatide | TABLET;ORAL | 208745 | SALIX | 04/13/2021 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/208745s011lbl.pdf#page=15 |
| Trulicity | Dulaglutide | INJECTABLE;INJECTION | 125469 | ELI LILLY AND CO | 03/12/2026 | http://www.accessdata.fda.gov/drugsatfda_docs/label/2026/125469s065lbl.pdf#page=32 |
| Truvada | Emtricitabine; Tenofovir Disoproxil Fumarate | TABLET;ORAL | 021752 | GILEAD | 04/29/2024 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021752Orig1s063lbl.pdf#page=35 |
| Truxima | Rituximab-Abbs | INJECTABLE;INJECTION | 761088 | CELLTRION INC | 06/09/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/761088s032lbl.pdf#page=45 |
| Tukysa | Tucatinib | TABLET | 213411 | SEAGEN INC A WHOLLY OWNED SUB OF PFIZER | 10/09/2026 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/213411s010lbl.pdf#page=32 |
| Turalio | Pexidartinib Hydrochloride | CAPSULE;ORAL | 211810 | DAIICHI SANKYO INC | 01/03/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/211810s013lbl.pdf#page=21 |
| Tussionex Pennkinetic | Chlorpheniramine Polistirex; Hydrocodone Polistirex | SUSPENSION, EXTENDED RELEASE;ORAL | 019111 | UCB INC | 06/28/2018 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/019111s022lbl.pdf#page=25 |
| Tuxarin ER | Chlorpheniramine Maleate; Codeine Phosphate | TABLET, EXTENDED RELEASE;ORAL | 206323 | MAINPOINTE | 07/15/2026 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/206323s009lbl.pdf#page=27 |
| Tuzistra XR | Chlorpheniramine Polistirex; Codeine Polistirex | SUSPENSION, EXTENDED RELEASE;ORAL | 207768 | AYTU | 12/15/2023 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/207768s013lbl.pdf#page=27 |
| Tyenne | Tocilizumab-Aazg | INJECTABLE;SUBCUTANEOUS | 761449 | FRESENIUS KABI USA, LLC | 05/20/2026 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/761449s006lbl.pdf#page=53 |
| Tyenne | Tocilizumab--Aazg | INJECTABLE;SUBCUTANEOUS | 761275 | FRESENIUS KABI USA LLC | 05/20/2026 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/761275s022lbl.pdf#page=53 |
| Tymlos | Abaloparatide | SOLUTION;SUBCUTANEOUS | 208743 | RADIUS HEALTH INC | 08/11/2026 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/208743s018lbl.pdf#page=22 |
| Tysabri | Natalizumab | VIAL; SINGLE-USE | 125104 | BIOGEN IDEC | 10/30/2023 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/125104s976s979lbl.pdf#page=32 |
| Tyzeka | Telbivudine | TABLET;ORAL | 022011 | NOVARTIS | 12/27/2018 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/022011s022,022154s019lbl.pdf#page=19 |
| Tyzeka | Telbivudine | SOLUTION;ORAL | 022154 | NOVARTIS | 12/27/2018 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/022011s022,022154s019lbl.pdf#page=19 |
| Tzield | Teplizumab | INJECTION;SOLUTION | 761183 | PROVENTION BIO, INC. | 06/15/2026 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/761183s010lbls014lbl.pdf#page=32 |
| Ukoniq | Umbralisib Tosylate | TABLET;ORAL | 213176 | TG THERAPS | 02/05/2021 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/213176s000lbl.pdf#page=19 |
| Ulenpo | Leuprolide Acetate | INJECTION | 213225 | SUN PHARMACEUTICAL INDUSTRIES LIMITED | 09/01/2026 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/213225Orig1s000lbl.pdf#page=12 |
| Uloric | Febuxostat | TABLET;ORAL | 021856 | TAKEDA PHARMS USA | 04/17/2023 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021856s015lbl.pdf#page=19 |
| Ultomiris | Ravulizumab-Cwvz | INJECTABLE;INJECTION | 761108 | ALEXION PHARM | 10/23/2026 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/761108s046lbl.pdf#page=46 |
| Ultracet | Acetaminophen; Tramadol Hydrochloride | TABLET;ORAL | 021123 | JANSSEN PHARMS | 02/13/2023 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021123s015lbl.pdf#page=46 |
| Ultram | Tramadol Hydrochloride | TABLET;ORAL | 020281 | JANSSEN PHARMS | 02/13/2023 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/020281s040lbl.pdf#page=42 |
| Ultram ER | Tramadol Hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 021692 | VALEANT PHARMS | 08/29/2017 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021692s015lbl.pdf#page=36 |
| Uplizna | Inebilizumab-Cdon | INJECTABLE;INJECTION | 761142 | VIELA BIO | 06/11/2020 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/761142s000lbl.pdf#page=17 |
| Valchlor | Mechlorethamine Hydrochloride | GEL;TOPICAL | 202317 | HELSINN | 05/01/2020 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/202317s009lbl.pdf#page=10 |
| Valium | Diazepam | TABLET;ORAL | 013263 | ROCHE | 09/22/2026 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/013263s095lbl.pdf#page=21 |
| Valtoco | Diazepam | SPRAY;NASAL | 211635 | NEURELIS INC | 01/13/2023 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/211635s008lbl.pdf#page=24 |
| Vanflyta | Quizartinib | TABLET;ORAL | 216993 | DAIICHI SANKYO | 06/25/2024 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/216993s000lbl.pdf#page=20 |
| Vantrela ER | Hydrocodone Bitartrate | TABLET, EXTENDED RELEASE;ORAL | 207975 | TEVA BRANDED PHARM | 05/26/2017 | http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/207975s000lbl.pdf#page=39 |
| Velsipity | Etrasimod Arganine | TABLET;ORAL | 216956 | PFIZER LABS | 08/12/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/216956s002lbl.pdf#page=25 |
| Venbysi XR | Venlafaxine Besylate | TABLET, EXTENDED RELEASE; ORAL | 215429 | ALMATICA | 08/18/2023 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/215429s001lbl.pdf#page=33 |
| Venclexta | Venetoclax | TABLET;ORAL | 208573 | ABBVIE INC | 05/20/2026 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/208573s032lblCorrected.pdf#page=53 |
| Venlafaxine Hydrochloride | Venlafaxine Hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 022104 | OSMOTICA PHARM | 08/18/2023 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022104s023lbl.pdf#page=35 |
| Veopoz | Pozelimab-Bbfg | INJECTABLE;INTRAVENOUS, SUBCUTANEOUS | 761339 | REGENERON PHARMACEUTICALS | 08/18/2023 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761339s000lbl.pdf#page=16 |
| Verquvo | Vericiguat | TABLET;ORAL | 214377 | Bayer AG | 05/10/2023 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/214377s002lbl.pdf#page=16 |
| Versacloz | Clozapine | ORAL;SUSPENSION | 203479 | TRUPHARMA, LLC | 06/13/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/203479s026lbl.pdf#page=38 |
| Vibativ | Telavancin | INJECTABLE; INJECTION | 022407 | THERAVANCE INC | 06/21/2013 | http://www.fda.gov/downloads/Drugs/DrugSafety/UCM183838.pdf |
| Vibativ | Telavancin Hydrochloride | POWDER;INTRAVENOUS | 022110 | CUMBERLAND PHARMS | 07/07/2020 | http://www.fda.gov/downloads/Drugs/DrugSafety/UCM183838.pdf |
| Viberzi | Eluxadoline | TABLET;ORAL | 206940 | ALLERGAN HOLDINGS | 06/17/2020 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/206940s007lbl.pdf#page=20 |
| Vicoprofen | Hydrocodone Bitartrate; Ibuprofen | TABLET;ORAL | 020716 | ABBVIE | 12/16/2016 | http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/020716s012s013s014s015s016lbl.pdf#page=36 |
| Victoza | Liraglutide Recombinant | SOLUTION;SUBCUTANEOUS | 022341 | NOVO NORDISK INC | 10/14/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/022341s046lbl.pdf#page=32 |
| Victrelis | Boceprevir | CAPSULE;ORAL | 202258 | MERCK SHARP DOHME | 01/30/2017 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/202258MG.pdf#page=27 |
| Videx | Didanosine | FOR SOLUTION;ORAL | 020156 | BRISTOL-MYERS SQUIBB | 12/17/2018 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020156s054lbl.pdf#page=34 |
| Videx EC | Didanosine | CAPSULE, DELAYED REL PELLETS;ORAL | 021183 | BRISTOL MYERS SQUIBB | 12/17/2018 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021183s029lbl.pdf#page=33 |
| Viekira Pak (Copackaged) | Dasabuvir Sodium; Ombitasvir, Paritaprevir, Ritonavir | TABLET;ORAL | 206619 | ABBVIE INC | 12/06/2019 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/206619s020lbl.pdf#page=49 |
| Viekira XR | Dasabuvir Sodium; Ombitasvir; Paritaprevir; Ritonavir | TABLET, EXTENDED RELEASE;ORAL | 208624 | ABBVIE INC | 12/06/2019 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/208624s008lbl.pdf#page=49 |
| Vigafyde | Vigabatrin | ORAL;SOLUTION | 217684 | PYROS PHARMACEUTICALS, INC | 09/03/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/217684s002s004lbl.pdf#page=18 |
| Viibryd | Vilazodone Hydrochloride | TABLET;ORAL | 022567 | ALLERGAN | 04/19/2024 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022567s024lbl.pdf#page=17 |
| Vimovo | Esomeprazole Magnesium; Naproxen | TABLET, DELAYED RELEASE;ORAL | 022511 | HORIZON | 11/21/2024 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/022511s030lbl.pdf#page=40 |
| Vimpat | Lacosamide | TABLET;ORAL | 022253 | UCB INC | 10/16/2023 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022253s057,022254s047,022255s039lbl.pdf#page=31 |
| Vimpat | Lacosamide | SOLUTION;INTRAVENOUS | 022254 | UCB INC | 10/16/2023 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022253s057,022254s047,022255s039lbl.pdf#page=31 |
| Vimpat | Lacosamide | SOLUTION;ORAL | 022255 | UCB INC | 10/16/2023 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022253s057,022254s047,022255s039lbl.pdf#page=31 |
| Viokace | Pancrelipase (Amylase;Lipase;Protease) | TABLET;ORAL | 022542 | VIOKACE | 02/28/2024 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022542s007lbl.pdf#page=12 |
| Viramune | Nevirapine | SUSPENSION;ORAL | 020933 | BOEHRINGER INGELHEIM | 06/10/2022 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020636s052,020933s043lbl.pdf#page=19 |
| Viramune | Nevirapine | TABLET;ORAL | 020636 | BOEHRINGER INGELHEIM | 06/10/2022 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020636s052,020933s043lbl.pdf#page=19 |
| Viramune XR | Nevirapine | TABLET, EXTENDED RELEASE;ORAL | 201152 | BOEHRINGER INGELHEIM | 06/10/2022 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/201152s014lbl.pdf#page=18 |
| Visicol | Sodium Phosphate, Dibasic Anhydrous; Sodium Phosphate, Monobasic, Monohydrate | TABLET;ORAL | 021097 | SALIX PHARMS | 03/07/2013 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/021097s016lbl.pdf#page=11 |
| Vituz | Chlorpheniramine Maleate; Hydrocodone Bitartrate | SOLUTION;ORAL | 204307 | PERSION | 06/28/2018 | http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/204307s004lbl.pdf#page=25 |
| Vivactil | Protriptyline Hydrochloride | TABLET;ORAL | 016012 | TEVA WOMENS | 07/17/2014 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/Vivactil.pdf |
| Vivitrol | Naltrexone | FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | 021897 | ALKERMES | 09/30/2022 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021897s052lbl.pdf#page=33 |
| Vivlodex | Meloxicam | CAPSULE;ORAL | 207233 | ZYLA | 11/21/2024 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/207233s005lbl.pdf#page=24 |
| Vogelxo | Testosterone | GEL;TRANSDERMAL | 204399 | UPSHER SMITH LABS | 07/11/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/204399s016lbl.pdf#page=24 |
| Vogelxo | Testosterone | GEL, METERED;TRANSDERMAL | 204399 | UPSHER SMITH LABS | 07/11/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/204399s016lbl.pdf#page=24 |
| Voltaren | Diclofenac Sodium | TABLET, DELAYED RELEASE;ORAL | 019201 | NOVARTIS | 04/28/2021 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/019201s048lbl.pdf#page=18 |
| Voltaren Arthritis Pain | Diclofenac Sodium | GEL;TOPICAL | 022122 | GLAXOSMITHKLINE CONS | 11/29/2023 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/022122s011lbl.pdf#page=22 |
| Voltaren-XR | Diclofenac Sodium | TABLET, EXTENDED RELEASE;ORAL | 020254 | NOVARTIS | 04/28/2021 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020254s030lbl.pdf#page=18 |
| Votrient | Pazopanib Hydrochloride | TABLET;ORAL | 022465 | NOVARTIS | 01/25/2024 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022465s031s032lbl.pdf#page=27 |
| Vraylar | Cariprazine Hydrochloride | CAPSULE;ORAL | 204370 | ALLERGAN | 11/22/2024 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/204370s012lbl.pdf#page=46 |
| Vyscoxa | Celecoxib | ORAL;SUSPENSION | 211759 | CARWIN PHARMACEUTICAL ASSOCIATES | 07/28/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/211759s000lbl.pdf#page=35 |
| Vyvanse | Lisdexamfetamine Dimesylate | CAPSULE;ORAL | 021977 | TAKEDA PHARMS USA | 06/23/2026 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/021977s052lbl.pdf#page=38 |
| Vyvanse | Lisdexamfetamine Dimesylate | TABLET, CHEWABLE;ORAL | 208510 | TAKEDA PHARMS USA | 06/23/2026 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/208510s009lbl.pdf#page=38 |
| Wegovy | Semaglutide | SOLUTION;SUBCUTANEOUS | 215256 | NOVO | 03/19/2026 | http://www.accessdata.fda.gov/drugsatfda_docs/label/2026/215256s029lbl.pdf#page=51 |
| Welireg | Belzutifan | TABLET;ORAL | 215383 | MERCK SHARP DOHME | 09/22/2026 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/215383s017lbl.pdf#page=32 |
| Wellbutrin | Bupropion Hydrochloride | TABLET;ORAL | 018644 | GLAXOSMITHKLINE | 11/05/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/018644s064lbl.pdf#page=26 |
| Wellbutrin SR | Bupropion Hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 020358 | GLAXOSMITHKLINE | 11/05/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/020358s070lbl.pdf#page=29 |
| Wellbutrin XL | Bupropion Hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 021515 | BAUSCH | 11/05/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/021515s049lbl.pdf#page=29 |
| Weltruza | Olanzapine | INJECTION, POWDER, FOR SUSPENSION, EXTENDED RELEASE | 219007 | TEVA NEUROSCIENCE INC | 10/09/2026 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/219007Orig1s000lbl.pdf#page=43 |
| Wezlana | Ustekinumab-Auub | INJECTABLE;SUBCUTANEOUS, INTRAVENOUS | 761331 | AMGEN INC | 05/19/2026 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/761285s006lbl761331s006lbl.pdf#page=38 |
| Wezlana | Ustekinumab-Auub | INJECTABLE;SUBCUTANEOUS, INTRAVENOUS | 761285 | AMGEN INC | 05/19/2026 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/761285s006lbl761331s006lbl.pdf#page=38 |
| Xalkori | Crizotinib | CAPSULE;ORAL | 202570 | PF PRISM CV | 09/07/2023 | http://www.accessdata.fda.gov/drugsatfda_docs/label/2023/202570s036lbl.pdf#page=46 |
| Xanax | Alprazolam | TABLET;ORAL | 018276 | UPJOHN | 01/13/2023 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/018276s059lbl.pdf#page=22 |
| Xanax XR | Alprazolam | TABLET, EXTENDED RELEASE;ORAL | 021434 | UPJOHN | 01/13/2023 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021434s022lbl.pdf#page=23 |
| Xarelto | Rivaroxaban | FOR SUSPENSION;ORAL | 215859 | JANSSEN PHARMS | 03/24/2026 | http://www.accessdata.fda.gov/drugsatfda_docs/label/2026/215859s007lbl.pdf#page=77 |
| Xarelto | Rivaroxaban | TABLET;ORAL | 202439 | JANSSEN PHARMS | 03/01/2022 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022406s039,202439s038lbl.pdf#page=77 |
| Xarelto | Rivaroxaban | TABLET;ORAL | 022406 | JANSSEN PHARMS | 03/24/2026 | http://www.accessdata.fda.gov/drugsatfda_docs/label/2026/022406s045lbl.pdf#page=77 |
| Xartemis XR | Acetaminophen; Oxycodone Hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 204031 | MALLINCKRODT INC | 09/18/2018 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/204031s004s005lbl.pdf#page=34 |
| Xcopri | Cenobamate | TABLET;ORAL | 212839 | SK LIFE | 08/18/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/212839s013lbl.pdf#page=27 |
| Xeljanz | Tofacitinib Citrate | SOLUTION;ORAL | 213082 | PFIZER | 09/22/2026 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/213082s015lbl.pdf#page=70 |
| Xeljanz | Tofacitinib Citrate | TABLET;ORAL | 203214 | PF PRISM CV | 09/22/2026 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/203214s042lbl.pdf#page=70 |
| Xeljanz XR | Tofacitinib Citrate | TABLET, EXTENDED RELEASE;ORAL | 208246 | PFIZER | 09/22/2026 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/208246s028lbl.pdf#page=70 |
| Xelstrym | Dextroamphetamine | SYSTEM;TRANSDERMAL | 215401 | NOVEN PHARMACEUTICALS INC | 09/23/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/215401s015lbl.pdf#page=29 |
| Xenazine | Tetrabenazine | TABLET;ORAL | 021894 | BAUSCH | 09/13/2017 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021894s013lbl.pdf#page=24 |
| Xeomin | Incobotulinumtoxina | INJECTABLE;INJECTION | 125360 | MERZ PHARMS | 09/08/2023 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/125360s097lbl.pdf#page=23 |
| Xiaflex | Collagenase Clostridium Histolyticum | SOLUTION; INJECTION | 125338 | AUXILIUM PHARMS | 07/12/2023 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/125338s111lbl.pdf#page=33 |
| Xigduo XR | Dapagliflozin; METformin Hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 205649 | ASTRAZENECA AB | 08/18/2026 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/205649s028s029lbl.pdf#page=65 |
| Xolair | Omalizumab | VIAL | 103976 | GENENTECH | 08/11/2026 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/103976s5253lbl.pdf#page=45 |
| Xospata | Gilteritinib Fumarate | TABLET;ORAL | 211349 | ASTELLAS | 01/12/2022 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/211349s003lbl.pdf#page=18 |
| Xpovio | Selinexor | TABLET;ORAL | 212306 | KARYOPHARM THERAPS | 05/04/2026 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/212306s018lbl.pdf#page=27 |
| Xromi | Hydroxyurea | SOLUTION/ORAL | 216593 | RARE DISEASE THERAPEUTICS, INC | 12/23/2024 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/216593Orig2s000lbl.pdf#page=12 |
| Xtampza ER | Oxycodone | CAPSULE, EXTENDED RELEASE;ORAL | 208090 | COLLEGIUM PHARM INC | 12/15/2023 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/208090s021lbl.pdf#page=40 |
| Xtrelus | Hydrocodone Bitartrate;Guaifenesin | TABLET;ORAL | 208085 | ECI PHARMACEUTICALS | 12/15/2023 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/208085s002lbl.pdf#page=22 |
| Xtrenbo and Enoby | Denosumab | INJECTION | 761439 | HIKMA PHARMACEUTICALS USA INC | 10/29/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/761439s000lbl.pdf#page=29 |
| Xultophy 100/3.6 | Insulin Degludec; Liraglutide | SOLUTION;SUBCUTANEOUS | 208583 | NOVO | 10/14/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/208583s026lbl.pdf#page=34 |
| Xyosted (Autoinjector) | Testosterone Enanthate | SOLUTION;SUBCUTANEOUS | 209863 | ANTARES PHARMA INC | 07/11/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/209863s020lbl.pdf#page=17 |
| Xyrem | Sodium Oxybate | SOLUTION;ORAL | 021196 | JAZZ PHARMS | 05/22/2024 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021196s042lbl.pdf#page=26 |
| Xywav | Calcium Oxybate; Magnesium Oxybate; Potassium Oxybate; Sodium Oxybate | SOLUTION;ORAL | 212690 | JAZZ | 05/22/2024 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/212690s011lbl.pdf#page=29 |
| Yervoy | Ipilimumab | INJECTABLE; INJECTION | 125377 | BRISTOL MYERS SQUIBB | 06/23/2026 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/125377s138lbl.pdf#page=78 |
| Yesintek | Ustekinumab-Kfce | INJECTABLE;SUBCUTANEOUS | 761406 | BIOCON BIOLOGICS INC | 08/18/2026 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/761406s002lbl.pdf#page=37 |
| Yesintek | Ustekinumab-Kfce | INJECTABLE;INTRAVENOUS, SUBCUTANEOUS | 761406 | BIOCON BIOLOGICS INC | 01/01/2000 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/761406s000lbl.pdf#page=37 |
| Yorvipath | Palopegteriparatide | INJECTABLE;SOLUTION | 216490 | ASCENDIS PHARMA BONE DISEASES A/S | 08/11/2026 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/216490s011lbl.pdf#page=18 |
| Yosprala | Aspirin; Omeprazole | TABLET, DELAYED RELEASE;ORAL | 205103 | GENUS LIFESCIENCES | 11/21/2024 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/205103s010lbl.pdf#page=29 |
| Yuflyma | Adalimumab-Aaty | INJECTABLE;SUBCUTANEOUS | 761219 | CELLTRION | 10/16/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/761219s018lbl.pdf#page=49 |
| Yusimry | Adalimumab-Aqvh | INJECTABLE;INJECTION | 761216 | COHERUS BIOSCIENCES INC | 10/06/2026 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/761216s011lbl.pdf#page=53 |
| Zarontin | Ethosuximide | CAPSULE;ORAL | 012380 | PARKE DAVIS | 10/28/2021 | http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/012380s034mg.pdf |
| Zegerid | Omeprazole; Sodium Bicarbonate | FOR SUSPENSION;ORAL | 021636 | SALIX | 07/18/2023 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021849s020,021636s025lbl.pdf#page=31 |
| Zegerid | Omeprazole; Sodium Bicarbonate | CAPSULE;ORAL | 021849 | SALIX | 07/18/2023 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021849s020,021636s025lbl.pdf#page=31 |
| Zelboraf | Vemurafenib | TABLET;ORAL | 202429 | HOFFMANN LA ROCHE | 05/18/2020 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/202429s016lbl.pdf#page=21 |
| Zenpep | Pancrelipase;Lipase;Protease;Amylase | CAPSULE, DELAYED RELEASE;ORAL | 022210 | AIMMUNE | 02/28/2024 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022210s024lbl.pdf#page=14 |
| Zenpep | Pancrelipase (Amylase;Lipase;Protease) | CAPSULE, DELAYED RELEASE;ORAL | 022210 | ZENPEP | 02/28/2024 | http://www.fda.gov/downloads/Drugs/DrugSafety/UCM180714.pdf |
| Zepbound | Tirzepatide | INJECTABLE;SOLUTION | 217806 | ELI LILLY AND CO | 09/01/2026 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/217806s041lbl.pdf#page=34 |
| Zeposia | Ozanimod Hydrochloride | CAPSULE;ORAL | 209899 | CELGENE INTL | 06/05/2024 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/209899s006s009lbl.pdf#page=25 |
| Zepzelca | Lurbinectedin | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | 213702 | JAZZ PHARMACEUTICALS IRELAND LIMITED | 10/06/2026 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/213702s013lbl.pdf#page=32 |
| Zerit | Stavudine | FOR SOLUTION;ORAL | 020413 | BRISTOL-MYERS SQUIBB | 12/17/2018 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020412s041,020413s033lbl.pdf#page=29 |
| Ziagen | Abacavir Sulfate | SOLUTION;ORAL | 020978 | VIIV HLTHCARE | 11/24/2020 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020977s035,020978s038lbl.pdf#page=27 |
| Zilbrysq | Zilucoplan | INJECTABLE;SUBCUTANEOUS | 216834 | UCB INC | 10/22/2026 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/216834s015lbl.pdf#page=21 |
| Zilurgisertib | Zilurgisertib | TABLET | 221198 | INCYTE CORPORATION | 10/06/2026 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/221198Orig1s000lbl.pdf#page=13 |
| Zinbryta | Daclizumab | INJECTABLE;INJECTION | 761029 | BIOGEN | 11/01/2017 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/761029s001lbl.pdf#page=24 |
| Zipsor | Diclofenac Potassium | CAPSULE;ORAL | 022202 | ASSERTIO | 11/21/2024 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/022202s016lbl.pdf#page=24 |
| Zituvimet | Sitagliptin, METformin Hydrochloride | TABLET;ORAL | 216743 | ZYDUS PHARMACEUTICALS | 08/18/2026 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/216743s006lbl.pdf#page=38 |
| Zituvio | Sitagliptin | TABLET;ORAL | 211566 | ZYDUS PHARMACEUTICALS INC | 10/18/2023 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/211566s000lbl.pdf#page=33 |
| Zohydro ER | Hydrocodone Bitartrate | CAPSULE, EXTENDED RELEASE;ORAL | 202880 | RECRO GAINESVILLE | 03/04/2021 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/202880s020lbl.pdf#page=30 |
| Zoloft | Sertraline Hydrochloride | CONCENTRATE;ORAL | 020990 | UPJOHN | 08/18/2023 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/019839s108,20990s062lbl.pdf#page=37 |
| Zoloft | Sertraline Hydrochloride | TABLET;ORAL | 019839 | UPJOHN | 08/18/2023 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/019839s108,20990s062lbl.pdf#page=37 |
| Zolpidem Tartrate | Zolpidem Tartrate | TABLET;ORAL | 076062 | STRIDES PHARMA | 03/07/2023 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/Zolpidem.pdf |
| Zolpidem Tartrate Capsules | Zolpidem Tartrate | CAPSULE;ORAL | 215721 | Almatica Pharma | 05/09/2023 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/215721s000lbl.pdf#page=27 |
| Zolpimist | Zolpidem Tartrate | SPRAY, METERED;ORAL | 022196 | AYTU | 08/18/2019 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022196s012lbl.pdf#page=19 |
| Zonegran | Zonisamide | CAPSULE;ORAL | 020789 | CONCORDIA | 04/13/2020 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020789s036lbl.pdf#page=25 |
| Zonisade | Zonisamide | SUSPENSION;ORAL | 214273 | AZURITY | 07/15/2022 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/214273s000lbl.pdf#page=27 |
| Zontivity | Vorapaxar Sulfate | TABLET;ORAL | 204886 | XSPIRE PHARMA | 11/07/2019 | http://www.fda.gov/downloads/Drugs/DrugSafety/UCM447698.pdf |
| Zortress | Everolimus | TABLET;ORAL | 021560 | NOVARTIS | 02/28/2024 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021560s033lbl.pdf#page=31 |
| Zorvolex | Diclofenac | CAPSULE;ORAL | 204592 | ZYLA | 11/21/2024 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/204592s014lbl.pdf#page=26 |
| Ztalmy | Ganaxolone | SUSPENSION;ORAL | 215904 | MARINUS PHARMACEUTICALS | 10/16/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/215904s011s013lbl.pdf#page=16 |
| Zubsolv | Buprenorphine Hydrochloride; Naloxone Hydrochloride | TABLET;SUBLINGUAL | 204242 | OREXO US INC | 03/20/2024 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/204242s027lbl.pdf#page=19 |
| Zulresso | Brexanolone | SOLUTION;INTRAVENOUS | 211371 | SAGE THERAP | 10/17/2023 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/211371s007lbl.pdf#page=20 |
| Zurampic | Lesinurad | TABLET;ORAL | 207988 | IRONWOOD PHARMS INC | 08/04/2016 | http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/207988lbl.pdf#page=17 |
| Zurzuvae | Zuranolone | CAPSULE;ORAL | 217369 | BIOGEN INC | 08/04/2023 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/217369Orig2s000Corrected_lbl.pdf#page=22 |
| Zutripro | Chlorpheniramine Maleate; Hydrocodone Bitartrate; Pseudoephedrine Hydrochloride | SOLUTION;ORAL | 022439 | PERSION | 06/28/2018 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/022439s010lbl.pdf#page=28 |
| Zyban | Bupropion Hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 020711 | GLAXOSMITHKLINE | 03/09/2021 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020711s052lbl.pdf#page=38 |
| Zydelig | Idelalisib | TABLET;ORAL | 205858 | GILEAD SCIENCES INC | 07/06/2022 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/205858s016lbl.pdf#page=25 |
| Zymfentra | Infliximab-Dyyb | INJECTABLE;SUBCUTANEOUS | 761358 | CELLTRION USA | 02/22/2024 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761358s000lbl.pdf#page=30 |
| Zynyz | Retifanlimab-Dlwr | INJECTABLE;INTRAVENOUS | 761334 | INCYTE | 03/30/2026 | http://www.accessdata.fda.gov/drugsatfda_docs/label/2026/761334s008lbl.pdf#page=28 |
| Zyprexa | Olanzapine | TABLET;ORAL | 020592 | LILLY | 01/30/2026 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/20592s079lbl.pdf#page=74 |
| Zyprexa | Olanzapine | INJECTABLE;INTRAMUSCULAR | 021253 | LILLY | 01/30/2026 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/21253s067lbl.pdf#page=74 |
| Zyprexa Relprevv | Olanzapine Pamoate | SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | 022173 | ELI LILLY CO | 05/19/2025 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/022173s043lbl022173s040lbl.pdf#page=32 |
| Zyprexa Zydis | Olanzapine | TABLET, ORALLY DISINTEGRATING;ORAL | 021086 | LILLY | 01/30/2026 | https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/21086s053lbl.pdf#page=74 |